{"gene":"BMPR1A","run_date":"2026-06-09T22:02:45","timeline":{"discoveries":[{"year":2002,"finding":"BMPR1A (ALK3) is required in mesenchymal cells of the Müllerian duct as a type I receptor for AMH-induced Müllerian duct regression during male sexual development; conditional disruption of Bmpr1a in mesenchyme leads to retention of oviducts and uteri in males.","method":"Conditional knockout (Cre/lox) with tissue-specific deletion in Müllerian duct mesenchyme; phenotypic analysis of male reproductive tract","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with specific and penetrant phenotype, replicated across multiple labs studying AMH signaling","pmids":["12368913"],"is_preprint":false},{"year":2002,"finding":"Cardiac myocyte-specific deletion of ALK3 (BMPR1A) causes defects in trabeculae, compact myocardium, interventricular septum, and endocardial cushion at mid-gestation; ALK3 is specifically required for expression of TGFβ2 in cardiac muscle, linking ALK3 signaling to a paracrine mediator of cushion morphogenesis.","method":"Cardiac myocyte-specific Cre/lox conditional knockout; phenotypic and molecular analysis including TGFβ2 expression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined molecular mechanism (TGFβ2 downregulation), replicated in follow-up cardiac studies","pmids":["11854453"],"is_preprint":false},{"year":2004,"finding":"Epithelial BMPR1A is required for tooth morphogenesis and for differentiation of the hair shaft and inner root sheath in postnatal follicles; loss of BMPR1A in epithelium results in absence of nuclear β-catenin, placing WNT pathway activation downstream of BMPR1A signaling in postnatal follicles.","method":"Cre-mediated conditional knockout in surface epithelium; expression analysis of transcriptional regulators (Msx1, Msx2, Foxn1, Gata3, Lef1) and nuclear β-catenin localization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with multiple molecular readouts establishing pathway hierarchy (BMPR1A upstream of WNT/β-catenin)","pmids":["15102710"],"is_preprint":false},{"year":2004,"finding":"BMPR1A signaling in hair follicle cells is essential for inner root sheath differentiation and for hair follicle cycling/renewal in adult skin.","method":"Hair follicle cell-specific conditional knockout (Cre/loxP); histological and molecular analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with specific phenotypic readout, independently confirmed by a second study (PMID 15102710)","pmids":["15084466"],"is_preprint":false},{"year":2005,"finding":"BMPR1A and BMPR1B are functionally redundant during early chondrogenesis; double conditional knockout mice develop severe generalized chondrodysplasia with absent Sox9, L-Sox5, and Sox6 expression in condensations, increased apoptosis, decreased proliferation, and loss of cartilage-specific extracellular matrix proteins.","method":"Cartilage-specific single and double conditional knockouts; skeletal analysis, expression profiling of Sox transcription factors","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — double conditional KO with genetic epistasis placing BMPR1A upstream of Sox9/L-Sox5/Sox6","pmids":["15781876"],"is_preprint":false},{"year":2005,"finding":"ALK3 (BMPR1A) is required in AV canal myocardium for development of the tricuspid mural and posterior leaflets, mitral septal leaflet, and annulus fibrosus; lineage analysis showed AV canal myocytes contribute directly to these structures.","method":"Cre/lox conditional deletion targeted to AV canal cardiac myocytes; lineage tracing; electrophysiological and histological analysis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with lineage tracing and defined structural phenotype","pmids":["16037571"],"is_preprint":false},{"year":2006,"finding":"Autocrine BMP/BMPR1A signaling in distal lung epithelium regulates proliferation, survival, and morphogenetic behavior; deletion of Bmpr1a in epithelium reduces proliferation and causes apoptosis, and mutant epithelium fails secondary budding in mesenchyme-free culture; Bmp4 epithelial deletion phenocopies this.","method":"Sftpc-cre conditional knockout; mesenchyme-free epithelial cultures in Matrigel; genetic rescue with Bax null background","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches including conditional KO, in vitro culture, and genetic rescue","pmids":["16414041"],"is_preprint":false},{"year":2006,"finding":"Endocardial/endothelial-specific deletion of Alk3 severely impairs epithelial-mesenchymal transformation (EMT) in the AV canal; Alk3 regulates expression/activation/subcellular localization of Smads and cell-cycle regulators in AV cushion mesenchymal cells.","method":"Tie1-Cre endothelial conditional knockout; in vivo section studies and in vitro explant assays quantifying mesenchymal cell number","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with both in vivo and in vitro explant validation, multiple molecular readouts","pmids":["16959237"],"is_preprint":false},{"year":2007,"finding":"BMP4-BMPR1A signaling in pancreatic beta cells is required for glucose-stimulated insulin secretion (GSIS); conditional attenuation of BMPR1A signaling in beta cells decreases expression of genes involved in insulin transcription, proinsulin processing, glucose sensing, and exocytosis, causing diabetes.","method":"Beta cell-specific conditional knockout; glucose tolerance tests; transgenic BMP4 overexpression; systemic BMP4 administration","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO plus transgenic gain-of-function plus pharmacological intervention, multiple orthogonal methods","pmids":["17339028"],"is_preprint":false},{"year":2007,"finding":"BMPR1a signaling in olig1-expressing progenitors suppresses oligodendrocyte lineage commitment and specification of calbindin-positive interneurons in the dorsomedial cortex, at least in part through regulation of subventricular zone progenitor cell cycle length.","method":"Cre/loxP conditional knockout in olig1-expressing cells; cell counting of oligodendrocyte populations at multiple postnatal timepoints; cell cycle analysis","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with quantitative cellular readouts and mechanistic link to cell cycle regulation","pmids":["17626200"],"is_preprint":false},{"year":2000,"finding":"Constitutively active BMP type I receptors ALK3 (BMPR1A) and ALK6 (as well as ALK2) phosphorylate Smad8, inducing Smad8 interaction with Smad4, nuclear translocation of Smad8, and cooperative transcriptional activation of the BMP-responsive Xvent2 promoter; TGFβ type I receptor ALK5 does not phosphorylate Smad8.","method":"In vitro reporter assays with constitutively active receptor constructs; co-immunoprecipitation; nuclear translocation assays; alkaline phosphatase induction assay","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis (constitutively active receptor), multiple orthogonal readouts in single study","pmids":["10814522"],"is_preprint":false},{"year":2003,"finding":"Co-expression of BMP type II receptor (BMPRII) influences aggregation and distribution of ALK3 at the cell surface; BMP-2 stimulation rearranges receptor complexes; co-expression of BMPRII with constitutively active ALK3 is required for Smad pathway activation; kinase activity of BMPRII is needed for ALK3 rearrangement.","method":"Image correlation spectroscopy; cell surface receptor clustering analysis in COS7 and A431 cells; kinase-inactive BMPRII mutant experiments","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel biophysical imaging method with functional mutant validation, single lab","pmids":["12829744"],"is_preprint":false},{"year":2003,"finding":"Expression of constitutively active ALK3 (ALK3QD) in transgenic mice causes renal medullary cystic dysplasia; ALK3 signaling promotes formation of SMAD1/β-catenin/SMAD4 molecular complexes in dysplastic renal tissue, indicating functional cooperativity between ALK3 and WNT/β-catenin pathways in kidney.","method":"Transgenic mouse model with ALK3QD; histological analysis; co-immunoprecipitation of SMAD1/β-catenin/SMAD4 complexes; Tcf-lacZ reporter assay","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic gain-of-function plus co-IP and reporter assay, single lab","pmids":["12736218"],"is_preprint":false},{"year":2003,"finding":"BMP4 signals through ALK3 (BMPR1A) and Smad5 in spermatogonia; BMP4 stimulation induces Smad4/5 nuclear translocation and formation of a DNA-binding complex with the transcriptional coactivator p300/CBP, and drives both mitogenic and differentiative effects including Kit expression in undifferentiated spermatogonia.","method":"Cell culture of spermatogonia with BMP4; immunofluorescence for nuclear translocation; DNA-binding complex analysis; [3H]thymidine incorporation; Kit expression assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal in vitro readouts (translocation, complex formation, proliferation, differentiation), single lab","pmids":["12857787"],"is_preprint":false},{"year":2008,"finding":"ALK3 (BMPR1A) controls ureteric bud branching morphogenesis in vivo; ureteric bud-specific deletion of Alk3 causes abnormal primary branching pattern, followed by fewer branches, and postnatal renal dysplasia with abnormal β-catenin and c-MYC expression in medullary tubules.","method":"Ureteric bud-specific conditional knockout (Alk3-UB-/-); renal morphological analysis at multiple developmental stages; molecular marker analysis","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with defined temporal phenotypic analysis and molecular readouts","pmids":["18178801"],"is_preprint":false},{"year":2008,"finding":"Prenatal abrogation of Alk3 in lung epithelial cells impairs distal airway formation, reduces cell proliferation and differentiation, disrupts surfactant secretion, and perturbs canonical Wnt signaling possibly through reduced Wnt inhibitory factor-1 expression.","method":"Inducible epithelial-specific conditional knockout (SPC-rtTA/TetO-Cre x Alk3-flox); analysis at multiple developmental timepoints; Wnt pathway marker expression","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — inducible conditional KO at two timepoints with defined molecular mechanism linking ALK3 to Wnt signaling via Wif1","pmids":["18258849"],"is_preprint":false},{"year":2009,"finding":"TβRIII (betaglycan) differentially modulates ALK3 and ALK6 subcellular trafficking and downstream signaling: TβRIII associates with ALK3 primarily through extracellular domains and causes cell surface retention of ALK3 (independent of β-arrestin2), specifically enhancing ALK3-mediated ID-1 upregulation; in contrast, TβRIII/ALK6 interaction requires cytoplasmic domains and promotes ALK6 internalization.","method":"Co-immunoprecipitation; cell surface retention assays; reporter gene assays (XVent2, 3GC2); domain deletion mutants; β-arrestin2 mutant TβRIII","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, domain-mapping mutants, and functional reporter assays, multiple orthogonal methods","pmids":["19726563"],"is_preprint":false},{"year":2009,"finding":"BMPR1A and ACVR1 (type I BMP receptors) activate multiple signaling pathways to regulate lens formation; BMPR1A specifically regulates cell survival, while ACVR1 regulates proliferation; for most lens development processes (placode proliferation, FoxE3 expression, αA-crystallin, lens invagination), BMP receptor signaling acts in a Smad-independent manner; only maintaining high Sox2 levels requires canonical Smad4-dependent signaling.","method":"Conditional knockout of Bmpr1a, Acvr1, Smad4, Smad1, Smad5 in lens ectoderm; cellular and molecular phenotypic analysis; epistasis analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic conditional KO of multiple pathway components establishing Smad-independent vs Smad-dependent pathway hierarchy","pmids":["19733164"],"is_preprint":false},{"year":2010,"finding":"BMPR1a and BMPR1b exert opposing effects on astrocytic hypertrophy after spinal cord injury; BMPR1a ablation in GFAP+ cells leads to defective astrocytic hypertrophy, while BMPR1b null mice develop hyperactive reactive astrocytes; the two receptors oppositely regulate posttranscriptional levels of astrocytic microRNA-21, which controls astrocyte size.","method":"Conditional knockout (GFAP-Cre); BMPR1b global knockout; double knockout rescue; in vitro astrocyte culture; microRNA-21 overexpression experiments","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO, global KO, double KO rescue, and in vitro overexpression establishing opposing functions and miR-21 as downstream effector","pmids":["20130193"],"is_preprint":false},{"year":2010,"finding":"Bmpr1a is required in the epiblast to maintain Wnt signaling in the visceral endoderm, which in turn establishes the anterior Dkk1 expression domain needed for directional AVE migration; Bmpr1a in epiblast induces Wnt3/Wnt3a expression, thereby maintaining WNT signaling that restricts Dkk1 to the anterior proximal visceral endoderm.","method":"Bmpr1a null and epiblast-specific conditional knockout (Sox2Cre); WNT3A rescue experiments in embryo culture; in situ hybridization for Dkk1 and Cer1","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional and null KO with pathway rescue experiment establishing BMPR1A upstream of WNT3A/Dkk1 axis","pmids":["20211162"],"is_preprint":false},{"year":2010,"finding":"Granulosa cell-expressed BMPR1A and BMPR1B act redundantly to suppress ovarian tumor development; BMPR1A single conditional knockout females are subfertile with reduced ovulation; double Bmpr1a/Bmpr1b mutants develop granulosa cell tumors with increased TGFβ and hedgehog signaling, similar to Smad1/Smad5 double knockouts.","method":"Single and double granulosa cell-specific conditional knockouts; tumor phenotype analysis; pathway marker analysis (TGFβ, hedgehog)","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis through double conditional KO placing BMPR1A/BMPR1B upstream of TGFβ/hedgehog in ovarian tumor suppression","pmids":["20363875"],"is_preprint":false},{"year":2010,"finding":"Bmpr1a signaling in palatal mesenchyme is required for cell proliferation in the primary and anterior secondary palate and for osteoblast differentiation during palatal bone formation; Bmpr1a loss reduces Msx1 and Fgf10 in palatal mesenchyme and Shh in palatal epithelium, indicating Bmp signaling regulates mesenchymal-epithelial crosstalk.","method":"Palatal mesenchyme-specific conditional knockout; proliferation analysis; in situ hybridization for Msx1, Fgf10, Shh","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple molecular pathway readouts establishing signaling hierarchy","pmids":["21185278"],"is_preprint":false},{"year":2011,"finding":"Conditional deletion of Bmpr1a in differentiated osteoclasts (Ctsk-Cre) increases osteoblastic bone formation rates in remodeling bone and increases bone volume; expression of bone-resorption markers was increased, suggesting BMPR1A signaling negatively regulates osteoclast differentiation; comparison with osteoblast-specific Bmpr1a deletion (Col1a1-Cre) showed opposite effects on bone formation rate.","method":"Osteoclast-specific and osteoblast-specific conditional knockouts; bone histomorphometry; bone marker analysis","journal":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","confidence":"High","confidence_rationale":"Tier 2 / Strong — two distinct conditional KO lines with cell-type-specific phenotypes, histomorphometric quantification","pmids":["21786321"],"is_preprint":false},{"year":2013,"finding":"BMP15 suppresses progesterone production in human granulosa cells by downregulating StAR via ALK3-mediated SMAD1/5/8 signaling; siRNA-mediated depletion of ALK3 reverses BMP15-induced SMAD1/5/8 phosphorylation and StAR expression changes.","method":"siRNA knockdown of ALK3 in immortalized (SVOG) and tumor (KGN) human granulosa cells; pharmacological inhibition with dorsomorphin and DMH-1; SMAD1/5/8 phosphorylation assays; StAR and progesterone measurement","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA knockdown confirmed in two cell lines plus pharmacological inhibition, multiple orthogonal methods","pmids":["24140593"],"is_preprint":false},{"year":2013,"finding":"BMP signaling via ALK3 in SHF-derived cells at the cardiac venous pole is required for proliferative expansion of the DMP progenitor population; conditional deletion of Alk3 from venous pole SHF cells impairs DMP formation and causes ostium primum defect with decreased proliferative index of SHF cells.","method":"SHF-specific conditional knockout; proliferative index measurement; DMP volume analysis; BMP/TGFβ signaling marker analysis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with quantitative proliferation and volume measurements, defined mechanistic pathway","pmids":["23584254"],"is_preprint":false},{"year":2014,"finding":"USP15 deubiquitylates ALK3 (BMPR1A): USP15 interacts with SMAD6 and ALK3, removes K48-linked polyubiquitin from ALK3, stabilizes ALK3 protein, and enhances BMP-induced SMAD1 phosphorylation and BMP target gene transcription; loss of USP15 increases ALK3 ubiquitylation and reduces BMP signaling and osteoblast differentiation.","method":"Co-immunoprecipitation; RNAi depletion; ubiquitylation assays (K48-linked); SMAD1 phosphorylation assays; reporter assays; Xenopus embryogenesis functional validation","journal":"Open biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct deubiquitylation assay with K48-linkage specificity, reciprocal co-IP, functional rescue in multiple systems","pmids":["24850914"],"is_preprint":false},{"year":2014,"finding":"HFE interacts with ALK3 (BMPR1A), inhibiting ALK3 ubiquitination and proteasomal degradation, thereby increasing ALK3 protein expression and cell-surface accumulation, which enhances SMAD1/5/8 phosphorylation and hepcidin expression; HH-associated HFE mutants (C282Y and H63D) fail to increase ALK3 cell-surface expression.","method":"Co-immunoprecipitation; ubiquitylation assays; cell-surface expression analysis; HFE overexpression/inhibition in Hep3B cells; Hfe knockout mouse liver analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP, ubiquitylation assay, cell-surface analysis, in vivo mouse validation, and disease-mutant characterization","pmids":["24904118"],"is_preprint":false},{"year":2014,"finding":"Alk3-mediated BMP signaling in epicardium-derived cells (EPDCs) is required for their contribution to the AV sulcus, annulus fibrosus, and parietal leaflets of AV valves; deletion of Alk3 in Wt1+ epicardial cells reduces EPDC contribution and causes myxomatous valve changes.","method":"Wt1-Cre epicardial conditional knockout; cell fate tracing; electrophysiology; histological and morphological analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with lineage tracing and electrophysiological analysis, single lab","pmids":["25300579"],"is_preprint":false},{"year":2015,"finding":"BMPR1A signaling in the uterus is necessary for blastocyst attachment; conditional knockout of ALK3 in the uterus causes sterility with defects in luminal epithelium polarity, increased microvilli density, elevated estrogen response, and unopposed epithelial proliferation; SMAD4 and progesterone receptor converge on Klf15 transcription to inhibit epithelial proliferation downstream of ALK3.","method":"Pgr-Cre conditional knockout; fertility analysis; uterine epithelial morphology; KLF15 dual transcriptional regulation analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined molecular convergence of two pathways (BMP-SMAD4 and progesterone receptor) on Klf15","pmids":["26721398"],"is_preprint":false},{"year":2015,"finding":"Physiological BMPR1A signaling in osteoblast lineage exerts dual opposing functions: it restricts preosteoblast (Sp7+) proliferation (suppressing trabecular bone formation) and promotes osteoblast activity/mTORC1 signaling for periosteal bone growth; Smad4 deletion has only minor effects, indicating Bmpr1a uses Smad4-independent effectors to suppress preosteoblast proliferation; mTORC1 inhibition abolishes BMP2-induced protein anabolism in vitro.","method":"Dmp1-Cre and inducible Sp7-Cre conditional knockouts; Smad4 conditional KO comparison; bone histomorphometry; mTORC1 signaling assays; in vitro BMP2 treatment with rapamycin","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple Cre lines, Smad4 epistasis analysis, and in vitro pharmacological validation of mTORC1 mechanism","pmids":["26657771"],"is_preprint":false},{"year":2015,"finding":"BMP4 and BMP7 suppress StAR expression and progesterone production in human granulosa-lutein cells via ALK3 (not ALK2 or ALK6) and SMAD1/5/8-SMAD4 signaling; siRNA knockdown of ALK3 specifically reverses these effects.","method":"siRNA knockdown of ALK3, ALK2, ALK6 in primary and immortalized human granulosa cells; pharmacological inhibition (dorsomorphin, DMH1, SB-431542); SMAD1/5/8 phosphorylation; SMAD4 siRNA knockdown","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA isoform-specific knockdown with pharmacological confirmation and SMAD4 epistasis, two independent cell models","pmids":["26302112"],"is_preprint":false},{"year":2015,"finding":"Bmpr1a in Myf5/MyoD-expressing myo-endothelial progenitors inhibits intramuscular adipogenesis; Bmpr1a ablation in these cells increases intramuscular fat and decreases myogenic activity, with severely decreased phospho-Smad 1/5/8 signaling; clonal studies show a cell-autonomous switch from myogenic to adipogenic differentiation.","method":"Myf5-Cre and MyoD-Cre conditional knockouts; VE-cadherin-Cre lineage tracing; clonal studies of myo-endothelial progenitors; pSmad1/5/8 signaling analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with clonal analysis and signaling readouts, lineage tracing controls","pmids":["24898859"],"is_preprint":false},{"year":2016,"finding":"BMP signaling through BMPR1A in osteocytes negatively regulates SOST (sclerostin) and RANKL expression; osteocyte-specific deletion of Bmpr1a (Dmp1-Cre) dramatically increases bone mass, decreases SOST and RANKL, increases OPG, increases β-catenin and Wnt target genes (Tcf1, Tcf3), and reduces osteoclast number.","method":"Osteocyte-specific Cre/lox conditional knockout (Dmp1-Cre); micro-CT; histomorphometry; molecular analysis of SOST, RANKL, OPG, β-catenin, Tcf1, Tcf3","journal":"Bone","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with comprehensive molecular readouts identifying downstream targets in signaling hierarchy","pmids":["27402532"],"is_preprint":false},{"year":2016,"finding":"BMP signaling through BMPR1A in osteoclasts suppresses osteoblast mineralization via regulation of connexin 43 (Cx43/Gja1); loss of Bmpr1a in osteoclasts increases Cx43 expression, and Cx43 knockdown in Bmpr1a-null osteoclasts reduces osteoblast mineralization in co-culture, identifying Cx43 as a downstream BMPR1A target mediating osteoclast-osteoblast communication.","method":"Co-culture of wild-type osteoblasts with Bmpr1a-null osteoclasts; siRNA knockdown of Cx43/Gja1; mineralization assays","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-culture plus siRNA knockdown, single lab, defined molecular mechanism","pmids":["27649478"],"is_preprint":false},{"year":2017,"finding":"BMPR1A is the major type I BMP receptor for Smad-dependent BMP signaling during skull development; pSmad1/5/9 levels are undetectable in Bmpr1a-null cells but not in Bmpr1b or Acvr1 null cells; heterozygous Bmpr1a (but not Bmpr1b or Acvr1) loss rescues constitutively active BMPR1A-induced craniosynostosis by reducing pSmad1/5/9 to normal levels.","method":"Conditional knockouts and heterozygous rescues of Bmpr1a, Bmpr1b, Acvr1 in neural crest cells; pSmad1/5/9 quantification in null cells; craniosynostosis phenotypic rescue analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic comparison of three type I receptor knockouts with genetic rescue and signaling quantification","pmids":["28641928"],"is_preprint":false},{"year":2017,"finding":"Endothelial ALK3/BMPR1A and ALK2/ACVR1 are required for postnatal retinal angiogenesis; endothelial-specific inducible deletion of Alk3 delays radial vascular expansion, phenocopying BMPR2 deletion, indicating ALK3 is a key type I receptor partnering with BMPR2 for proangiogenic BMP signaling in retinal vessels.","method":"Inducible endothelial-specific conditional knockout; retinal angiogenesis analysis; comparison with Bmpr2, Alk1, Alk2 deletions","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic comparison of multiple receptor conditional KOs establishing receptor partnership","pmids":["28232325"],"is_preprint":false},{"year":2018,"finding":"IL-6 enhances BMP-2-induced osteogenic and adipogenic differentiation by promoting cell-surface translocation of BMPR1A, thereby amplifying BMPR1A-mediated BMP/Smad and p38 MAPK pathways.","method":"In vitro differentiation assays with human BMSCs; cell-surface translocation assay for BMPR1A; Smad and p38 MAPK signaling analysis; in vivo rat ectopic bone model with IL-6 injection","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo experiments with receptor surface translocation and two downstream pathway readouts, single lab","pmids":["29396550"],"is_preprint":false},{"year":2018,"finding":"ALK3 undergoes ligand-independent homodimerization; ALK3 forms heterodimers with ALK2 in a ligand-dependent manner (BMP2 or BMP6 required); both ALK3-ALK3 and ALK2-ALK3 complexes induce hepcidin expression in Huh7 cells; Alk2/Alk3 double hepatocyte-specific deficiency causes greater iron overload than Alk3 deficiency alone.","method":"Co-immunoprecipitation in Huh7 cells with and without BMP ligands; hepatocyte-specific double knockout mice; iron overload phenotyping; hepcidin expression assays","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP with ligand dependence analysis, in vivo genetic epistasis with double KO, functional hepcidin assay","pmids":["30227271"],"is_preprint":false},{"year":2018,"finding":"In AML, BMP4 controls expression of the survival factor ΔNp73 through binding to BMPR1A, which in turn directly induces NANOG expression and increases stem-like features in leukemic cells (increased ALDH activity); BMPR1A transcript and membrane receptor are upregulated in AML cells and further increased by BMP4 exposure.","method":"Downstream signaling analysis in AML patient cells and cell lines; functional ALDH assay; correlation of ΔNp73, BMPR1A, NANOG expression with patient outcome","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pathway analysis with functional readout (ALDH), but limited mechanistic dissection of direct binding vs signaling intermediates; single lab","pmids":["30262802"],"is_preprint":false},{"year":2018,"finding":"ALK2/ALK3 mediate BMP2-induced downregulation of pentraxin 3 (PTX3) in human granulosa-lutein cells via SMAD1/5/8-SMAD4; siRNA knockdown of ALK2/3 or BMPR2/ACVR2A receptors reverses BMP2-induced SMAD1/5/8 phosphorylation and PTX3 downregulation.","method":"siRNA knockdown of individual receptors and SMADs; SMAD1/5/8 phosphorylation assays; PTX3 mRNA/protein measurement; BMP receptor inhibitors","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA isoform-specific knockdown in two cell models, pharmacological confirmation, single lab","pmids":["28977600"],"is_preprint":false},{"year":2019,"finding":"BMP signaling through ALK3/BMPR1A and SMAD1/SMAD5 controls venous endothelial identity by driving Ephb4 expression; a venous endothelium-specific Ephb4 enhancer shows enriched SMAD1/5 binding and requires SMAD binding motifs; Ephb4 expression is lost upon perturbation of BMP/ALK3 signaling in mice and zebrafish without affecting arterial identity.","method":"Genetic perturbations in mice and zebrafish; ChIP/enhancer analysis of SMAD1/5 binding to Ephb4 venous enhancer; SMAD binding motif mutagenesis; in situ hybridization for venous/arterial markers","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic and molecular epistasis in two species, enhancer binding and motif requirement established, multiple orthogonal methods","pmids":["30692543"],"is_preprint":false},{"year":2019,"finding":"S-palmitoylation of BMPR1A regulates its subcellular localization and trafficking, and consequently BMP signaling levels; genetic manipulation of palmitoylation sites on BMPR1A alters its membrane localization and signaling, leading to enhanced oligodendrogenesis from neural stem cells in the mouse brain.","method":"Unbiased palmitoylation screen of NSC proteome; site-directed mutagenesis of palmitoylation sites; subcellular localization imaging; BMP signaling assays; in vivo neural lineage analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — unbiased screen identifying palmitoylation, mutagenesis of acylation sites with functional rescue, in vivo lineage consequences","pmids":["31772009"],"is_preprint":false},{"year":2021,"finding":"BMPR1A is essential for suture stem cell (SuSC) self-renewal; SuSC-specific disruption of Bmpr1a causes precocious differentiation and craniosynostosis initiated at the suture midline (the stem cell niche); BMPR1A serves as a cell-surface marker of human SuSCs.","method":"SuSC-specific conditional knockout; ex vivo stem cell culture; lineage analysis; craniosynostosis phenotyping; human SuSC surface marker characterization","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with ex vivo stem cell validation and human SuSC marker characterization, multiple orthogonal methods","pmids":["33658353"],"is_preprint":false},{"year":2022,"finding":"LAPTM5 recruits WWP2, which binds BMPR1A and mediates its lysosomal sorting, ubiquitination, and degradation; chloroquine (lysosomal inhibitor) restores BMPR1A expression; LAPTM5-driven BMPR1A degradation blocks lung-derived BMP signaling, sustaining cancer stem cell traits and promoting lung-specific metastasis in renal cancer.","method":"Co-immunoprecipitation of LAPTM5-WWP2-BMPR1A complex; ubiquitylation assays; chloroquine rescue of BMPR1A expression; conditional KO and overexpression in cancer cells; in vivo metastasis models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP of trimeric complex, ubiquitylation assay, pharmacological and genetic rescue, in vivo validation","pmids":["35842443"],"is_preprint":false},{"year":2023,"finding":"Upon BMPR1A activation in endothelial cells, ID2 physically interacts with and sequesters ZEB1, attenuating ZEB1-driven transcription of Tgfbr2, which reduces EC responses to TGFβ and prevents excessive EndoMT; endothelial-specific deletion of Bmpr1a in adult mice causes PAH-like symptoms via excessive EndoMT; siRNA against Tgfbr2 delivered to endothelium ameliorates PAH in Bmpr1a iECKO mice.","method":"Endothelial-specific inducible conditional knockout (Bmpr1a iECKO); co-IP of ID2-ZEB1 interaction; lineage tracing of endothelial-derived smooth muscle cells; siRNA lipid nanoparticle rescue; TGFβ response assays","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO, co-IP establishing ID2-ZEB1 physical interaction, lineage tracing, and in vivo rescue establishing causal pathway","pmids":["36166408"],"is_preprint":false},{"year":2000,"finding":"BMP-2 and the constitutively active form of ALK3 inhibit renal collecting duct morphogenesis via Smad1 phosphorylation, Smad1/Smad4 complex formation, and Smad1 nuclear translocation; HGF overcomes BMP-2/ALK3 inhibition without interrupting any of these known Smad1 signaling events, indicating parallel pathways downstream of their receptors.","method":"Stable expression of constitutively active ALK3 in mIMCD-3 cells; Smad1 phosphorylation and nuclear translocation assays; BMP-responsive promoter (Tlx2) reporter; rescue with HGF and other RTK ligands","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — constitutively active receptor in collecting duct cells with multiple signaling readouts, but limited to negative result for HGF-BMP crosstalk at Smad level","pmids":["10633078"],"is_preprint":false},{"year":2018,"finding":"HFE signals predominantly via ALK3 to induce hepcidin in vivo; HFE overexpression in control mice increases hepcidin and pSmad1/5 levels, but overexpression of HFE in hepatocyte-specific Alk3-deficient mice produces no change in hepcidin or pSmad1/5, establishing ALK3 as the required in vivo mediator of HFE-driven hepcidin regulation.","method":"AAV2/8-Hfe-Flag injection in hepatocyte-specific Alk3 knockout vs control mice; hepcidin expression; pSmad1/5 measurement; iron and blood parameter analysis","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo gain-of-function in conditional KO background providing direct genetic epistasis evidence","pmids":["30271947"],"is_preprint":false},{"year":2009,"finding":"BMPR1A is the preferred BMP2 type I receptor in LβT2 gonadotroph cells for regulating Fshb transcription; siRNA knockdown of endogenous BMPR1A (but not ACVR1 or BMPR1B) significantly impairs BMP2 synergism with activin A on FSHβ reporter activity; constitutively active BMPR1A with BMPR2 stimulates SMAD1/5 phosphorylation and Fshb transcription.","method":"siRNA knockdown of BMPR1A, ACVR1, BMPR1B; constitutively active receptor co-expression; Fshb promoter-reporter assay; SMAD1/5 phosphorylation assays","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific siRNA knockdown with pharmacological confirmation, single lab, single cell type","pmids":["19211807"],"is_preprint":false},{"year":2011,"finding":"Alk3 controls nephron number and testosterone production via lineage-specific mechanisms in intermediate mesoderm progenitors; in kidney, Alk3 deficiency reduces metanephric blastema contribution and expression of nephron progenitor markers Osr1 and SIX2 via phospho-p38 MAPK pathway; in testis, Alk3 regulates Leydig cell formation via pSMAD1/5/8 signaling.","method":"Intermediate mesoderm progenitor-specific conditional knockout; lineage contribution analysis; marker expression; phospho-p38 MAPK and pSMAD1/5/8 analysis in respective tissues","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — lineage-specific conditional KO with pathway-specific signaling readouts (p38 vs SMAD) in two different tissues","pmids":["21613322"],"is_preprint":false},{"year":2023,"finding":"BMPR1A mediates BMP signaling-induced deep quiescence in pallial neural stem cells postnatally; Bmpr1a manipulation demonstrates its key role in synchronizing quiescence induction and blockade of glutamatergic neuron differentiation to silence pallial germinal activity after birth.","method":"Single-cell RNA sequencing of postnatal dorsal V-SVZ; Bmpr1a genetic manipulation; analysis of NSC quiescence states and neurogenic output","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic manipulation with scRNA-seq molecular characterization, single lab","pmids":["37146152"],"is_preprint":false}],"current_model":"BMPR1A (ALK3) is a broadly expressed type I BMP receptor serine/threonine kinase that forms heteromeric complexes with BMP type II receptors (primarily BMPR2), undergoes ligand-independent homodimerization, and is regulated by post-translational mechanisms including ubiquitination/deubiquitination (by SMAD6/SMURF and USP15), lysosomal sorting (via LAPTM5-WWP2), and S-palmitoylation that controls its membrane localization; upon BMP ligand binding it phosphorylates R-SMADs (SMAD1/5/8), enabling their association with SMAD4 and nuclear translocation to regulate target gene transcription, while also activating Smad-independent pathways (p38 MAPK, mTORC1); co-receptors including HFE, TβRIII (betaglycan), and FGFR3 modulate its signaling by stabilizing cell-surface expression or altering trafficking; its context-dependent roles—established by conditional knockout studies—span chondrogenesis, osteogenesis, cardiac valvulogenesis and ventricular development, Müllerian duct regression, hair follicle cycling, lung and kidney branching morphogenesis, pancreatic beta cell insulin secretion, uterine implantation, neural stem cell quiescence, venous endothelial identity, and gastrointestinal polyposis suppression, with its downstream pathway hierarchy variously placing it upstream of Sox9/L-Sox5/Sox6 (cartilage), Wnt/β-catenin, TGFβ2, Dkk1, SOST/RANKL/OPG, ID2-ZEB1-TGFBR2 (EndoMT), and SMAD4-KLF15 (uterine) signaling axes."},"narrative":{"mechanistic_narrative":"BMPR1A (ALK3) is a type I BMP receptor serine/threonine kinase that, upon ligand binding, phosphorylates receptor-SMADs (SMAD1/5/8) to drive their association with SMAD4, nuclear translocation, and BMP-responsive transcription [PMID:10814522, PMID:12857787]. It functions within heteromeric receptor complexes: ALK3 undergoes ligand-independent homodimerization and forms ligand-dependent heterodimers with ALK2, and co-expression of the type II receptor BMPR2 is required for surface receptor rearrangement and SMAD activation [PMID:12829744, PMID:30227271]. Receptor abundance and signaling output are tuned by post-translational control of receptor stability and trafficking — USP15 removes K48-linked polyubiquitin from ALK3 to stabilize it, HFE blocks ALK3 ubiquitination to raise cell-surface levels, the LAPTM5–WWP2 module ubiquitinates ALK3 for lysosomal degradation, and S-palmitoylation governs its membrane localization [PMID:24850914, PMID:24904118, PMID:31772009, PMID:35842443]. Beyond canonical SMAD signaling, ALK3 engages SMAD-independent effectors including p38 MAPK and mTORC1 [PMID:26657771, PMID:21613322]. Through these pathways ALK3 acts as a context-dependent hub across development and tissue homeostasis: it mediates AMH-induced Müllerian duct regression, cardiac valvulogenesis and ventricular morphogenesis, chondrogenesis (redundantly with BMPR1B, upstream of Sox9/L-Sox5/Sox6), skull suture stem-cell self-renewal, hair follicle and lung/kidney branching morphogenesis, and pancreatic beta-cell insulin secretion [PMID:12368913, PMID:11854453, PMID:15781876, PMID:17339028, PMID:33658353, PMID:18178801]. Its downstream hierarchy repeatedly intersects WNT/β-catenin signaling and dedicated effector axes such as SMAD4–KLF15 in uterus, SOST/RANKL/OPG in bone, and ID2–ZEB1–TGFBR2 controlling endothelial-to-mesenchymal transition, with endothelial ALK3 maintaining venous identity via Ephb4 and protecting against PAH-like remodeling [PMID:26721398, PMID:27402532, PMID:36166408, PMID:30692543].","teleology":[{"year":2000,"claim":"Established that ALK3 is a BMP-specific (not TGFβ) type I receptor that phosphorylates R-SMADs to drive SMAD4 complex formation and BMP-responsive transcription, defining its core signaling output.","evidence":"Constitutively active receptor reporter assays, co-IP, and nuclear translocation assays for Smad8; constitutively active ALK3 in collecting duct cells with Smad1 readouts","pmids":["10814522","10633078"],"confidence":"High","gaps":["Used constitutively active constructs rather than ligand-driven activation","Did not address selectivity among BMP ligands at the endogenous receptor"]},{"year":2002,"claim":"Conditional knockouts first revealed ALK3's in vivo tissue requirements, linking it to AMH-induced Müllerian duct regression and to cardiac morphogenesis through paracrine TGFβ2 induction.","evidence":"Tissue-specific Cre/lox deletion in Müllerian duct mesenchyme and cardiac myocytes with phenotypic and molecular analysis","pmids":["12368913","11854453"],"confidence":"High","gaps":["Mechanism connecting ALK3 to TGFβ2 transcription not resolved","Receptor partners in these tissues not defined in vivo"]},{"year":2003,"claim":"Defined the receptor-complex requirements for signaling — that BMPRII kinase activity drives ALK3 surface rearrangement — and placed ALK3 upstream of WNT/β-catenin in renal tissue.","evidence":"Image correlation spectroscopy of surface clustering with kinase-inactive BMPRII; transgenic ALK3QD with SMAD1/β-catenin/SMAD4 co-IP and Tcf reporter","pmids":["12829744","12736218"],"confidence":"Medium","gaps":["Surface clustering studied in overexpression systems","Physical basis of ALK3–β-catenin pathway convergence not structurally defined"]},{"year":2004,"claim":"Showed that epithelial ALK3 acts upstream of WNT/β-catenin activation in skin appendages, establishing a recurring BMP→WNT hierarchy in organogenesis.","evidence":"Surface-epithelium conditional knockout with nuclear β-catenin and transcription-factor expression analysis; hair follicle conditional knockout","pmids":["15102710","15084466"],"confidence":"High","gaps":["Direct molecular link from ALK3/SMAD to β-catenin nuclear entry not mapped","Ligand source in follicle not defined here"]},{"year":2005,"claim":"Genetic epistasis placed ALK3 (redundantly with BMPR1B) upstream of the Sox9/L-Sox5/Sox6 cartilage transcription program and defined distinct cardiac valve lineage requirements.","evidence":"Cartilage single/double conditional knockouts with Sox factor profiling; AV-canal myocyte conditional deletion with lineage tracing","pmids":["15781876","16037571"],"confidence":"High","gaps":["Functional redundancy obscures ALK3-specific targets","Direct vs indirect regulation of Sox genes unresolved"]},{"year":2006,"claim":"Demonstrated autocrine ALK3 signaling controlling epithelial proliferation, survival, and EMT in lung and AV cushion, expanding its role to cell-fate and morphogenetic behaviors.","evidence":"Sftpc-cre and Tie1-Cre conditional knockouts with mesenchyme-free culture, genetic Bax rescue, and explant EMT assays","pmids":["16414041","16959237"],"confidence":"High","gaps":["SMAD-dependent vs -independent contribution not separated","Downstream cell-cycle effectors only partially identified"]},{"year":2007,"claim":"Extended ALK3 function to endocrine and neural-progenitor contexts, linking BMP4–ALK3 to glucose-stimulated insulin secretion and to progenitor cell-cycle control governing oligodendrocyte fate.","evidence":"Beta-cell conditional KO with GTT, transgenic and pharmacological BMP4; olig1-progenitor conditional KO with cell counting and cell-cycle analysis","pmids":["17339028","17626200"],"confidence":"High","gaps":["Direct transcriptional targets in beta cells not defined","Mechanism coupling ALK3 to cell-cycle length unresolved"]},{"year":2009,"claim":"Identified co-receptor and isoform selectivity: TβRIII retains ALK3 at the surface to enhance ID-1 signaling, and ALK3 (not ALK2/ALK6) is the preferred receptor for specific BMP transcriptional responses.","evidence":"Reciprocal co-IP with domain-mapping mutants and reporter assays; isoform-specific siRNA in gonadotroph cells with constitutively active receptors","pmids":["19726563","19211807"],"confidence":"High","gaps":["Determinants of receptor-isoform preference not generalized across cell types","β-arrestin-independent retention mechanism incompletely defined"]},{"year":2010,"claim":"Conditional knockouts mapped ALK3 onto multiple WNT-linked developmental axes (epiblast Wnt3a→Dkk1, ureteric bud branching, palatal mesenchymal-epithelial crosstalk) and revealed opposing BMPR1A/BMPR1B effects via miR-21 in astrocytes.","evidence":"Sox2Cre/null and tissue-specific conditional KOs with WNT3A rescue, in situ hybridization, and miR-21 overexpression","pmids":["20211162","18178801","21185278","20130193"],"confidence":"High","gaps":["Direct transcriptional intermediaries between ALK3 and Wnt ligand expression not identified","Mechanism of opposing receptor outputs on miR-21 unresolved"]},{"year":2011,"claim":"Showed ALK3 uses different effector branches in a tissue-specific manner — p38 MAPK for nephron progenitor markers versus pSMAD1/5/8 for Leydig cell formation — establishing branch selection as context-dependent.","evidence":"Intermediate mesoderm progenitor conditional KO with tissue-specific p38 and SMAD signaling readouts; osteoclast/osteoblast conditional KOs with histomorphometry","pmids":["21613322","21786321"],"confidence":"High","gaps":["What dictates p38 vs SMAD branch selection unknown","Cell-type-intrinsic determinants of opposing bone outcomes undefined"]},{"year":2014,"claim":"Defined post-translational control of ALK3 abundance: USP15 deubiquitinates and stabilizes ALK3 while HFE blocks its ubiquitination to raise surface levels, both amplifying SMAD signaling, with HFE disease mutants losing this function.","evidence":"Co-IP, K48-linkage ubiquitylation assays, RNAi, SMAD1 phospho assays, and in vivo mouse/Xenopus validation","pmids":["24850914","24904118"],"confidence":"High","gaps":["E3 ligase opposing USP15 on ALK3 not identified here","Quantitative contribution of receptor turnover to physiological output unknown"]},{"year":2015,"claim":"Resolved SMAD-dependent vs -independent effector usage and defined dedicated downstream axes — Smad4–KLF15 in uterus and an mTORC1-dependent anabolic branch in osteoblasts — broadening ALK3's mechanistic repertoire.","evidence":"Multiple conditional KOs with Smad4 epistasis, KLF15 dual-pathway transcription analysis, mTORC1 assays with rapamycin, and lens-tissue receptor comparisons","pmids":["26721398","26657771","19733164","24898859"],"confidence":"High","gaps":["Identity of Smad4-independent effectors suppressing preosteoblast proliferation incompletely defined","Mechanism coupling ALK3 to mTORC1 not mapped"]},{"year":2016,"claim":"Identified osteocyte and osteoclast BMPR1A targets (SOST/RANKL/OPG and connexin 43) that mediate cell-cell communication controlling bone mass.","evidence":"Dmp1-Cre osteocyte conditional KO with micro-CT and molecular profiling; osteoclast-osteoblast co-culture with Cx43 knockdown","pmids":["27402532","27649478"],"confidence":"High","gaps":["Direct vs indirect regulation of SOST/RANKL not established","Cx43 regulation studied only in co-culture"]},{"year":2017,"claim":"Established BMPR1A as the dominant type I receptor for SMAD-dependent BMP signaling in cranial development, since only Bmpr1a loss abolishes pSmad1/5/9 and dose-dependently controls craniosynostosis.","evidence":"Systematic conditional KO and heterozygous rescue of Bmpr1a, Bmpr1b, Acvr1 in neural crest with pSmad quantification; endothelial-specific KO retinal angiogenesis comparison","pmids":["28641928","28232325"],"confidence":"High","gaps":["Basis for ALK3 dominance over other type I receptors unresolved","Receptor-partner stoichiometry in vivo not defined"]},{"year":2018,"claim":"Clarified receptor-complex assembly and additional trafficking control: ligand-independent ALK3 homodimers and ligand-dependent ALK2-ALK3 heterodimers both signal, and IL-6 promotes ALK3 surface translocation to amplify SMAD/p38 output.","evidence":"Co-IP with/without ligand and hepatocyte double KO iron phenotyping; surface-translocation and signaling assays with IL-6; AML pathway and granulosa-cell siRNA studies","pmids":["30227271","29396550","30262802","28977600"],"confidence":"High","gaps":["Functional differences between homodimeric and heterodimeric complexes not dissected","Direct BMPR1A binding vs intermediate signaling in AML not separated"]},{"year":2018,"claim":"Provided in vivo genetic proof that ALK3 is the required mediator of HFE-driven hepcidin induction, integrating receptor-stability regulation with systemic iron homeostasis.","evidence":"AAV-Hfe overexpression in hepatocyte-specific Alk3 KO vs control mice with hepcidin and pSmad1/5 readouts","pmids":["30271947"],"confidence":"High","gaps":["Whether HFE acts solely through stabilization or also via complex assembly not resolved"]},{"year":2019,"claim":"Identified S-palmitoylation as a lipid modification controlling ALK3 membrane localization and signaling strength, with consequences for neural stem cell oligodendrogenesis, and defined a direct ALK3/SMAD1/5 transcriptional target (Ephb4) governing venous identity.","evidence":"Palmitoylation proteomic screen with acylation-site mutagenesis and in vivo lineage analysis; SMAD1/5 ChIP/enhancer and motif mutagenesis at the Ephb4 venous enhancer in mouse and zebrafish","pmids":["31772009","30692543"],"confidence":"High","gaps":["Palmitoyl transferase/thioesterase enzymes acting on ALK3 not identified","Generality of Ephb4 regulation beyond venous endothelium untested"]},{"year":2021,"claim":"Established ALK3 as a determinant of adult stem-cell self-renewal, marking and maintaining suture stem cells, with loss causing precocious differentiation and craniosynostosis.","evidence":"SuSC-specific conditional KO with ex vivo stem cell culture, lineage analysis, and human SuSC surface-marker characterization","pmids":["33658353"],"confidence":"High","gaps":["Downstream effectors of ALK3 in stem-cell maintenance not defined","Ligand source in the suture niche unspecified"]},{"year":2022,"claim":"Defined a lysosomal degradation route — LAPTM5 recruiting WWP2 to ubiquitinate and degrade BMPR1A — that suppresses BMP signaling and promotes cancer stemness and organotropic metastasis.","evidence":"Co-IP of LAPTM5-WWP2-BMPR1A trimeric complex, ubiquitylation assays, chloroquine rescue, and in vivo metastasis models","pmids":["35842443"],"confidence":"High","gaps":["Signal triggering LAPTM5-mediated sorting unknown","Relationship to proteasomal/USP15 regulation not integrated"]},{"year":2023,"claim":"Revealed ALK3's protective role in adult vasculature and brain: it restrains EndoMT through an ID2-ZEB1-TGFBR2 axis to prevent PAH-like remodeling and induces deep quiescence in pallial neural stem cells.","evidence":"Endothelial inducible conditional KO with ID2-ZEB1 co-IP, lineage tracing, and Tgfbr2 siRNA rescue; scRNA-seq with Bmpr1a manipulation in postnatal V-SVZ","pmids":["36166408","37146152"],"confidence":"High","gaps":["How ALK3 activation drives ID2 to outcompete ZEB1 not mechanistically detailed","Effectors of quiescence induction downstream of ALK3 incompletely defined"]},{"year":null,"claim":"How a single receptor selects among SMAD-dependent, p38 MAPK, and mTORC1 branches, and how the competing ubiquitination, deubiquitination, palmitoylation, and lysosomal-sorting machineries are integrated to set context-specific signaling thresholds, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model for effector-branch selection","Quantitative interplay of post-translational regulators not reconstituted","Structural basis of complex assembly with type II receptors and co-receptors undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[10,13,25,34]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[10,34]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[11,37]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[11,26,36,41]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[43]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10,11,37]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,4,14,21]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[25,26,41,43]}],"complexes":[],"partners":["BMPR2","ALK2/ACVR1","TGFBR3","HFE","USP15","WWP2","LAPTM5","SMAD4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P36894","full_name":"Bone morphogenetic protein receptor type-1A","aliases":["Activin receptor-like kinase 3","ALK-3","Serine/threonine-protein kinase receptor R5","SKR5"],"length_aa":532,"mass_kda":60.2,"function":"On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for BMP2, BMP4, GDF5 and GDF6. Positively regulates chondrocyte differentiation through GDF5 interaction. Mediates induction of adipogenesis by GDF6. May promote the expression of HAMP, potentially via its interaction with BMP2 (By similarity)","subcellular_location":"Cell membrane; Cell surface","url":"https://www.uniprot.org/uniprotkb/P36894/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BMPR1A","classification":"Not Classified","n_dependent_lines":195,"n_total_lines":1208,"dependency_fraction":0.16142384105960264},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BMPR1A","total_profiled":1310},"omim":[{"mim_id":"615886","title":"SCAFFOLDING CK1-ANCHORING PROTEIN G; SACK1G","url":"https://www.omim.org/entry/615886"},{"mim_id":"614823","title":"AORTIC VALVE DISEASE 2; AOVD2","url":"https://www.omim.org/entry/614823"},{"mim_id":"614708","title":"SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 3; SCUBE3","url":"https://www.omim.org/entry/614708"},{"mim_id":"613127","title":"CHORDIN-LIKE 2; CHRDL2","url":"https://www.omim.org/entry/613127"},{"mim_id":"612242","title":"CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME","url":"https://www.omim.org/entry/612242"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BMPR1A"},"hgnc":{"alias_symbol":["ALK3","CD292"],"prev_symbol":["ACVRLK3"]},"alphafold":{"accession":"P36894","domains":[{"cath_id":"2.10.60.10","chopping":"56-140","consensus_level":"medium","plddt":85.0169,"start":56,"end":140},{"cath_id":"3.30.200.20","chopping":"219-311","consensus_level":"high","plddt":88.2415,"start":219,"end":311},{"cath_id":"1.10.510.10","chopping":"316-531","consensus_level":"high","plddt":94.2889,"start":316,"end":531}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P36894","model_url":"https://alphafold.ebi.ac.uk/files/AF-P36894-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P36894-F1-predicted_aligned_error_v6.png","plddt_mean":82.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BMPR1A","jax_strain_url":"https://www.jax.org/strain/search?query=BMPR1A"},"sequence":{"accession":"P36894","fasta_url":"https://rest.uniprot.org/uniprotkb/P36894.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P36894/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P36894"}},"corpus_meta":[{"pmid":"15781876","id":"PMC_15781876","title":"Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15781876","citation_count":341,"is_preprint":false},{"pmid":"12368913","id":"PMC_12368913","title":"Requirement of Bmpr1a for Müllerian duct regression during male sexual development.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12368913","citation_count":338,"is_preprint":false},{"pmid":"15102710","id":"PMC_15102710","title":"Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15102710","citation_count":311,"is_preprint":false},{"pmid":"11854453","id":"PMC_11854453","title":"Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11854453","citation_count":231,"is_preprint":false},{"pmid":"15235019","id":"PMC_15235019","title":"The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.","date":"2004","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15235019","citation_count":199,"is_preprint":false},{"pmid":"11536076","id":"PMC_11536076","title":"Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11536076","citation_count":185,"is_preprint":false},{"pmid":"12857787","id":"PMC_12857787","title":"Developmental expression of BMP4/ALK3/SMAD5 signaling pathway in the mouse testis: a potential role of BMP4 in spermatogonia differentiation.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12857787","citation_count":168,"is_preprint":false},{"pmid":"12417513","id":"PMC_12417513","title":"Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis.","date":"2002","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12417513","citation_count":131,"is_preprint":false},{"pmid":"20130193","id":"PMC_20130193","title":"BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20130193","citation_count":129,"is_preprint":false},{"pmid":"12136244","id":"PMC_12136244","title":"Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers.","date":"2002","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12136244","citation_count":128,"is_preprint":false},{"pmid":"16414041","id":"PMC_16414041","title":"Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16414041","citation_count":126,"is_preprint":false},{"pmid":"17339028","id":"PMC_17339028","title":"BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion.","date":"2007","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17339028","citation_count":117,"is_preprint":false},{"pmid":"16037571","id":"PMC_16037571","title":"Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus.","date":"2005","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16037571","citation_count":113,"is_preprint":false},{"pmid":"18178612","id":"PMC_18178612","title":"Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis.","date":"2008","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/18178612","citation_count":100,"is_preprint":false},{"pmid":"20363875","id":"PMC_20363875","title":"Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20363875","citation_count":96,"is_preprint":false},{"pmid":"16685657","id":"PMC_16685657","title":"Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16685657","citation_count":93,"is_preprint":false},{"pmid":"18823382","id":"PMC_18823382","title":"The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis.","date":"2008","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18823382","citation_count":89,"is_preprint":false},{"pmid":"24904118","id":"PMC_24904118","title":"HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24904118","citation_count":86,"is_preprint":false},{"pmid":"21185278","id":"PMC_21185278","title":"Bmpr1a signaling plays critical roles in palatal shelf growth and palatal bone formation.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21185278","citation_count":84,"is_preprint":false},{"pmid":"15084466","id":"PMC_15084466","title":"BMPR1A signaling is necessary for hair follicle cycling and hair shaft differentiation in mice.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15084466","citation_count":81,"is_preprint":false},{"pmid":"19359354","id":"PMC_19359354","title":"Temporal regulation of BMP2, BMP6, BMP15, GDF9, BMPR1A, BMPR1B, BMPR2 and TGFBR1 mRNA expression in the oocyte, granulosa and theca cells of developing preovulatory follicles in the pig.","date":"2009","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19359354","citation_count":79,"is_preprint":false},{"pmid":"16959237","id":"PMC_16959237","title":"Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16959237","citation_count":76,"is_preprint":false},{"pmid":"24140593","id":"PMC_24140593","title":"BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/24140593","citation_count":75,"is_preprint":false},{"pmid":"28163952","id":"PMC_28163952","title":"Unintended targeting of Dmp1-Cre reveals a critical role for Bmpr1a signaling in the gastrointestinal mesenchyme of adult mice.","date":"2017","source":"Bone research","url":"https://pubmed.ncbi.nlm.nih.gov/28163952","citation_count":75,"is_preprint":false},{"pmid":"21786321","id":"PMC_21786321","title":"Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.","date":"2011","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/21786321","citation_count":71,"is_preprint":false},{"pmid":"19733164","id":"PMC_19733164","title":"The type I BMP receptors, Bmpr1a and Acvr1, activate multiple signaling pathways to regulate lens formation.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19733164","citation_count":65,"is_preprint":false},{"pmid":"19502417","id":"PMC_19502417","title":"Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity.","date":"2009","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/19502417","citation_count":64,"is_preprint":false},{"pmid":"33658353","id":"PMC_33658353","title":"BMPR1A maintains skeletal stem cell properties in craniofacial development and craniosynostosis.","date":"2021","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33658353","citation_count":63,"is_preprint":false},{"pmid":"23639540","id":"PMC_23639540","title":"Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.","date":"2013","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/23639540","citation_count":61,"is_preprint":false},{"pmid":"26657771","id":"PMC_26657771","title":"Dual function of Bmpr1a signaling in restricting preosteoblast proliferation and stimulating osteoblast activity in mouse.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26657771","citation_count":61,"is_preprint":false},{"pmid":"30692543","id":"PMC_30692543","title":"Venous identity requires BMP signalling through ALK3.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30692543","citation_count":58,"is_preprint":false},{"pmid":"26721398","id":"PMC_26721398","title":"Uterine ALK3 is essential during the window of implantation.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26721398","citation_count":57,"is_preprint":false},{"pmid":"16525031","id":"PMC_16525031","title":"Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function.","date":"2006","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16525031","citation_count":57,"is_preprint":false},{"pmid":"23584254","id":"PMC_23584254","title":"Expression of the BMP receptor Alk3 in the second heart field is essential for development of the dorsal mesenchymal protrusion and atrioventricular septation.","date":"2013","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/23584254","citation_count":55,"is_preprint":false},{"pmid":"32398773","id":"PMC_32398773","title":"Disease expression in juvenile polyposis syndrome: a retrospective survey on a cohort of 221 European patients and comparison with a literature-derived cohort of 473 SMAD4/BMPR1A pathogenic variant carriers.","date":"2020","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32398773","citation_count":55,"is_preprint":false},{"pmid":"12736218","id":"PMC_12736218","title":"Elevated SMAD1/beta-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12736218","citation_count":55,"is_preprint":false},{"pmid":"17626200","id":"PMC_17626200","title":"BMPR1a signaling determines numbers of oligodendrocytes and calbindin-expressing interneurons in the cortex.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17626200","citation_count":51,"is_preprint":false},{"pmid":"24882581","id":"PMC_24882581","title":"MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24882581","citation_count":51,"is_preprint":false},{"pmid":"23399955","id":"PMC_23399955","title":"Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.","date":"2013","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23399955","citation_count":50,"is_preprint":false},{"pmid":"10814522","id":"PMC_10814522","title":"Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10814522","citation_count":50,"is_preprint":false},{"pmid":"29490276","id":"PMC_29490276","title":"P2RY1/ALK3-Expressing Cells within the Adult Human Exocrine Pancreas Are BMP-7 Expandable and Exhibit Progenitor-like Characteristics.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29490276","citation_count":48,"is_preprint":false},{"pmid":"35288625","id":"PMC_35288625","title":"Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35288625","citation_count":48,"is_preprint":false},{"pmid":"17998461","id":"PMC_17998461","title":"Abnormal conduction and morphology in the atrioventricular node of mice with atrioventricular canal targeted deletion of Alk3/Bmpr1a receptor.","date":"2007","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/17998461","citation_count":46,"is_preprint":false},{"pmid":"24850914","id":"PMC_24850914","title":"USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling.","date":"2014","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/24850914","citation_count":44,"is_preprint":false},{"pmid":"18178801","id":"PMC_18178801","title":"BMP receptor ALK3 controls collecting system development.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/18178801","citation_count":44,"is_preprint":false},{"pmid":"12829744","id":"PMC_12829744","title":"Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12829744","citation_count":44,"is_preprint":false},{"pmid":"18258849","id":"PMC_18258849","title":"Prenatal lung epithelial cell-specific abrogation of Alk3-bone morphogenetic protein signaling causes neonatal respiratory distress by disrupting distal airway formation.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18258849","citation_count":44,"is_preprint":false},{"pmid":"29396550","id":"PMC_29396550","title":"IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29396550","citation_count":43,"is_preprint":false},{"pmid":"18079409","id":"PMC_18079409","title":"Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling.","date":"2007","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/18079409","citation_count":42,"is_preprint":false},{"pmid":"26274893","id":"PMC_26274893","title":"Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26274893","citation_count":41,"is_preprint":false},{"pmid":"24480809","id":"PMC_24480809","title":"miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.","date":"2014","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24480809","citation_count":40,"is_preprint":false},{"pmid":"35842443","id":"PMC_35842443","title":"Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35842443","citation_count":39,"is_preprint":false},{"pmid":"27402532","id":"PMC_27402532","title":"Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.","date":"2016","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/27402532","citation_count":39,"is_preprint":false},{"pmid":"28232325","id":"PMC_28232325","title":"Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28232325","citation_count":38,"is_preprint":false},{"pmid":"27387537","id":"PMC_27387537","title":"Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway.","date":"2016","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/27387537","citation_count":37,"is_preprint":false},{"pmid":"10633078","id":"PMC_10633078","title":"BMP-2/ALK3 and HGF signal in parallel to regulate renal collecting duct morphogenesis.","date":"2000","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/10633078","citation_count":36,"is_preprint":false},{"pmid":"19726563","id":"PMC_19726563","title":"The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.","date":"2009","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19726563","citation_count":36,"is_preprint":false},{"pmid":"26302112","id":"PMC_26302112","title":"BMP4 and BMP7 Suppress StAR and Progesterone Production via ALK3 and SMAD1/5/8-SMAD4 in Human Granulosa-Lutein Cells.","date":"2015","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26302112","citation_count":35,"is_preprint":false},{"pmid":"24898859","id":"PMC_24898859","title":"Intramuscular adipogenesis is inhibited by myo-endothelial progenitors with functioning Bmpr1a signalling.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24898859","citation_count":35,"is_preprint":false},{"pmid":"30262802","id":"PMC_30262802","title":"A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30262802","citation_count":34,"is_preprint":false},{"pmid":"32764110","id":"PMC_32764110","title":"BMPR1A is necessary for chondrogenesis and osteogenesis, whereas BMPR1B prevents hypertrophic differentiation.","date":"2020","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/32764110","citation_count":32,"is_preprint":false},{"pmid":"16152648","id":"PMC_16152648","title":"Vessels' morphology in SMAD4 and BMPR1A-related juvenile polyposis.","date":"2005","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16152648","citation_count":32,"is_preprint":false},{"pmid":"31769494","id":"PMC_31769494","title":"BMPR1A and BMPR1B Missense Mutations Cause Primary Ovarian Insufficiency.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31769494","citation_count":31,"is_preprint":false},{"pmid":"19211807","id":"PMC_19211807","title":"Bone morphogenetic protein 2 signals via BMPR1A to regulate murine follicle-stimulating hormone beta subunit transcription.","date":"2009","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/19211807","citation_count":31,"is_preprint":false},{"pmid":"30884445","id":"PMC_30884445","title":"Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach.","date":"2019","source":"Computational biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30884445","citation_count":30,"is_preprint":false},{"pmid":"29684814","id":"PMC_29684814","title":"Transcriptional and translational abundance of Bone morphogenetic protein (BMP) 2, 4, 6, 7 and their receptors BMPR1A, 1B and BMPR2 in buffalo ovarian follicle and the role of BMP4 and BMP7 on estrogen production and survival of cultured granulosa cells.","date":"2018","source":"Research in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/29684814","citation_count":30,"is_preprint":false},{"pmid":"34282140","id":"PMC_34282140","title":"Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34282140","citation_count":29,"is_preprint":false},{"pmid":"28977600","id":"PMC_28977600","title":"ALK2/ALK3-BMPR2/ACVR2A Mediate BMP2-Induced Downregulation of Pentraxin 3 Expression in Human Granulosa-Lutein Cells.","date":"2017","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28977600","citation_count":29,"is_preprint":false},{"pmid":"19438883","id":"PMC_19438883","title":"Hereditary mixed polyposis syndrome due to a BMPR1A mutation.","date":"2009","source":"Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland","url":"https://pubmed.ncbi.nlm.nih.gov/19438883","citation_count":29,"is_preprint":false},{"pmid":"20211162","id":"PMC_20211162","title":"Bmpr1a is required for proper migration of the AVE through regulation of Dkk1 expression in the pre-streak mouse embryo.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20211162","citation_count":28,"is_preprint":false},{"pmid":"33256557","id":"PMC_33256557","title":"BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma.","date":"2020","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/33256557","citation_count":27,"is_preprint":false},{"pmid":"28641928","id":"PMC_28641928","title":"BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28641928","citation_count":27,"is_preprint":false},{"pmid":"19442313","id":"PMC_19442313","title":"Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a.","date":"2009","source":"BMC musculoskeletal disorders","url":"https://pubmed.ncbi.nlm.nih.gov/19442313","citation_count":27,"is_preprint":false},{"pmid":"29175363","id":"PMC_29175363","title":"Bone morphogenetic protein signaling through ACVR1 and BMPR1A negatively regulates bone mass along with alterations in bone composition.","date":"2017","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/29175363","citation_count":26,"is_preprint":false},{"pmid":"20843829","id":"PMC_20843829","title":"Discovery of the BMPR1A promoter and germline mutations that cause juvenile polyposis.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20843829","citation_count":26,"is_preprint":false},{"pmid":"25300579","id":"PMC_25300579","title":"Alk3 mediated Bmp signaling controls the contribution of epicardially derived cells to the tissues of the atrioventricular junction.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25300579","citation_count":26,"is_preprint":false},{"pmid":"30535663","id":"PMC_30535663","title":"MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.","date":"2019","source":"Cardiovascular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/30535663","citation_count":26,"is_preprint":false},{"pmid":"23805267","id":"PMC_23805267","title":"Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23805267","citation_count":26,"is_preprint":false},{"pmid":"27113526","id":"PMC_27113526","title":"Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.","date":"2016","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/27113526","citation_count":26,"is_preprint":false},{"pmid":"27649478","id":"PMC_27649478","title":"BMP Signaling Mediated by BMPR1A in Osteoclasts Negatively Regulates Osteoblast Mineralization Through Suppression of Cx43.","date":"2016","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27649478","citation_count":25,"is_preprint":false},{"pmid":"26780949","id":"PMC_26780949","title":"Differential requirement of bone morphogenetic protein receptors Ia (ALK3) and Ib (ALK6) in early embryonic patterning and neural crest development.","date":"2016","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26780949","citation_count":24,"is_preprint":false},{"pmid":"22067610","id":"PMC_22067610","title":"BMPR1A is a candidate gene for congenital heart defects associated with the recurrent 10q22q23 deletion syndrome.","date":"2011","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22067610","citation_count":24,"is_preprint":false},{"pmid":"31772009","id":"PMC_31772009","title":"Palmitoylation of BMPR1a regulates neural stem cell fate.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31772009","citation_count":23,"is_preprint":false},{"pmid":"25158185","id":"PMC_25158185","title":"Critical role of Bmpr1a in mandibular condyle growth.","date":"2014","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/25158185","citation_count":23,"is_preprint":false},{"pmid":"26585335","id":"PMC_26585335","title":"Enrichment of Adipose-Derived Stromal Cells for BMPR1A Facilitates Enhanced Adipogenesis.","date":"2016","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26585335","citation_count":23,"is_preprint":false},{"pmid":"36166408","id":"PMC_36166408","title":"BMPR1A promotes ID2-ZEB1 interaction to suppress excessive endothelial to mesenchymal transition.","date":"2023","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/36166408","citation_count":22,"is_preprint":false},{"pmid":"26171675","id":"PMC_26171675","title":"Somatic alterations in juvenile polyps from BMPR1A and SMAD4 mutation carriers.","date":"2015","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26171675","citation_count":22,"is_preprint":false},{"pmid":"37146152","id":"PMC_37146152","title":"Single-cell analysis of the postnatal dorsal V-SVZ reveals a role for Bmpr1a signaling in silencing pallial germinal activity.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37146152","citation_count":22,"is_preprint":false},{"pmid":"15026806","id":"PMC_15026806","title":"Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases.","date":"2004","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15026806","citation_count":22,"is_preprint":false},{"pmid":"23097200","id":"PMC_23097200","title":"BMP-6 and BMPR-1a are up-regulated in the growth plate of the fractured tibia.","date":"2012","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/23097200","citation_count":22,"is_preprint":false},{"pmid":"30227271","id":"PMC_30227271","title":"ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2.","date":"2018","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30227271","citation_count":21,"is_preprint":false},{"pmid":"21613322","id":"PMC_21613322","title":"Alk3 controls nephron number and androgen production via lineage-specific effects in intermediate mesoderm.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21613322","citation_count":21,"is_preprint":false},{"pmid":"17588538","id":"PMC_17588538","title":"Deficient Alk3-mediated BMP signaling causes prenatal omphalocele-like defect.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17588538","citation_count":19,"is_preprint":false},{"pmid":"26279380","id":"PMC_26279380","title":"Bmpr1a Signaling in Cartilage Development and Endochondral Bone Formation.","date":"2015","source":"Vitamins and hormones","url":"https://pubmed.ncbi.nlm.nih.gov/26279380","citation_count":18,"is_preprint":false},{"pmid":"29495003","id":"PMC_29495003","title":"Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29495003","citation_count":18,"is_preprint":false},{"pmid":"12630959","id":"PMC_12630959","title":"Identification of a novel BMPR1A germline mutation in a Korean juvenile polyposis patient without SMAD4 mutation.","date":"2003","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12630959","citation_count":18,"is_preprint":false},{"pmid":"30271947","id":"PMC_30271947","title":"The hemochromatosis protein HFE signals predominantly via the BMP type I receptor ALK3 in vivo.","date":"2018","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/30271947","citation_count":16,"is_preprint":false},{"pmid":"35616049","id":"PMC_35616049","title":"BMP7-based peptide agonists of BMPR1A protect the left ventricle against pathological remodeling induced by pressure overload.","date":"2022","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/35616049","citation_count":16,"is_preprint":false},{"pmid":"32360900","id":"PMC_32360900","title":"Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones.","date":"2020","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/32360900","citation_count":16,"is_preprint":false},{"pmid":"24608800","id":"PMC_24608800","title":"Alk3/Alk3b and Smad5 mediate BMP signaling during lymphatic development in zebrafish.","date":"2014","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/24608800","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51739,"output_tokens":12979,"usd":0.174951,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":24699,"output_tokens":6738,"usd":0.145973,"stage2_stop_reason":"end_turn"},"total_usd":0.320924,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"BMPR1A (ALK3) is required in mesenchymal cells of the Müllerian duct as a type I receptor for AMH-induced Müllerian duct regression during male sexual development; conditional disruption of Bmpr1a in mesenchyme leads to retention of oviducts and uteri in males.\",\n      \"method\": \"Conditional knockout (Cre/lox) with tissue-specific deletion in Müllerian duct mesenchyme; phenotypic analysis of male reproductive tract\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with specific and penetrant phenotype, replicated across multiple labs studying AMH signaling\",\n      \"pmids\": [\"12368913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Cardiac myocyte-specific deletion of ALK3 (BMPR1A) causes defects in trabeculae, compact myocardium, interventricular septum, and endocardial cushion at mid-gestation; ALK3 is specifically required for expression of TGFβ2 in cardiac muscle, linking ALK3 signaling to a paracrine mediator of cushion morphogenesis.\",\n      \"method\": \"Cardiac myocyte-specific Cre/lox conditional knockout; phenotypic and molecular analysis including TGFβ2 expression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined molecular mechanism (TGFβ2 downregulation), replicated in follow-up cardiac studies\",\n      \"pmids\": [\"11854453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Epithelial BMPR1A is required for tooth morphogenesis and for differentiation of the hair shaft and inner root sheath in postnatal follicles; loss of BMPR1A in epithelium results in absence of nuclear β-catenin, placing WNT pathway activation downstream of BMPR1A signaling in postnatal follicles.\",\n      \"method\": \"Cre-mediated conditional knockout in surface epithelium; expression analysis of transcriptional regulators (Msx1, Msx2, Foxn1, Gata3, Lef1) and nuclear β-catenin localization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with multiple molecular readouts establishing pathway hierarchy (BMPR1A upstream of WNT/β-catenin)\",\n      \"pmids\": [\"15102710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BMPR1A signaling in hair follicle cells is essential for inner root sheath differentiation and for hair follicle cycling/renewal in adult skin.\",\n      \"method\": \"Hair follicle cell-specific conditional knockout (Cre/loxP); histological and molecular analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with specific phenotypic readout, independently confirmed by a second study (PMID 15102710)\",\n      \"pmids\": [\"15084466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"BMPR1A and BMPR1B are functionally redundant during early chondrogenesis; double conditional knockout mice develop severe generalized chondrodysplasia with absent Sox9, L-Sox5, and Sox6 expression in condensations, increased apoptosis, decreased proliferation, and loss of cartilage-specific extracellular matrix proteins.\",\n      \"method\": \"Cartilage-specific single and double conditional knockouts; skeletal analysis, expression profiling of Sox transcription factors\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double conditional KO with genetic epistasis placing BMPR1A upstream of Sox9/L-Sox5/Sox6\",\n      \"pmids\": [\"15781876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ALK3 (BMPR1A) is required in AV canal myocardium for development of the tricuspid mural and posterior leaflets, mitral septal leaflet, and annulus fibrosus; lineage analysis showed AV canal myocytes contribute directly to these structures.\",\n      \"method\": \"Cre/lox conditional deletion targeted to AV canal cardiac myocytes; lineage tracing; electrophysiological and histological analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with lineage tracing and defined structural phenotype\",\n      \"pmids\": [\"16037571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Autocrine BMP/BMPR1A signaling in distal lung epithelium regulates proliferation, survival, and morphogenetic behavior; deletion of Bmpr1a in epithelium reduces proliferation and causes apoptosis, and mutant epithelium fails secondary budding in mesenchyme-free culture; Bmp4 epithelial deletion phenocopies this.\",\n      \"method\": \"Sftpc-cre conditional knockout; mesenchyme-free epithelial cultures in Matrigel; genetic rescue with Bax null background\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches including conditional KO, in vitro culture, and genetic rescue\",\n      \"pmids\": [\"16414041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Endocardial/endothelial-specific deletion of Alk3 severely impairs epithelial-mesenchymal transformation (EMT) in the AV canal; Alk3 regulates expression/activation/subcellular localization of Smads and cell-cycle regulators in AV cushion mesenchymal cells.\",\n      \"method\": \"Tie1-Cre endothelial conditional knockout; in vivo section studies and in vitro explant assays quantifying mesenchymal cell number\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with both in vivo and in vitro explant validation, multiple molecular readouts\",\n      \"pmids\": [\"16959237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BMP4-BMPR1A signaling in pancreatic beta cells is required for glucose-stimulated insulin secretion (GSIS); conditional attenuation of BMPR1A signaling in beta cells decreases expression of genes involved in insulin transcription, proinsulin processing, glucose sensing, and exocytosis, causing diabetes.\",\n      \"method\": \"Beta cell-specific conditional knockout; glucose tolerance tests; transgenic BMP4 overexpression; systemic BMP4 administration\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO plus transgenic gain-of-function plus pharmacological intervention, multiple orthogonal methods\",\n      \"pmids\": [\"17339028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BMPR1a signaling in olig1-expressing progenitors suppresses oligodendrocyte lineage commitment and specification of calbindin-positive interneurons in the dorsomedial cortex, at least in part through regulation of subventricular zone progenitor cell cycle length.\",\n      \"method\": \"Cre/loxP conditional knockout in olig1-expressing cells; cell counting of oligodendrocyte populations at multiple postnatal timepoints; cell cycle analysis\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with quantitative cellular readouts and mechanistic link to cell cycle regulation\",\n      \"pmids\": [\"17626200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Constitutively active BMP type I receptors ALK3 (BMPR1A) and ALK6 (as well as ALK2) phosphorylate Smad8, inducing Smad8 interaction with Smad4, nuclear translocation of Smad8, and cooperative transcriptional activation of the BMP-responsive Xvent2 promoter; TGFβ type I receptor ALK5 does not phosphorylate Smad8.\",\n      \"method\": \"In vitro reporter assays with constitutively active receptor constructs; co-immunoprecipitation; nuclear translocation assays; alkaline phosphatase induction assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis (constitutively active receptor), multiple orthogonal readouts in single study\",\n      \"pmids\": [\"10814522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Co-expression of BMP type II receptor (BMPRII) influences aggregation and distribution of ALK3 at the cell surface; BMP-2 stimulation rearranges receptor complexes; co-expression of BMPRII with constitutively active ALK3 is required for Smad pathway activation; kinase activity of BMPRII is needed for ALK3 rearrangement.\",\n      \"method\": \"Image correlation spectroscopy; cell surface receptor clustering analysis in COS7 and A431 cells; kinase-inactive BMPRII mutant experiments\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel biophysical imaging method with functional mutant validation, single lab\",\n      \"pmids\": [\"12829744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Expression of constitutively active ALK3 (ALK3QD) in transgenic mice causes renal medullary cystic dysplasia; ALK3 signaling promotes formation of SMAD1/β-catenin/SMAD4 molecular complexes in dysplastic renal tissue, indicating functional cooperativity between ALK3 and WNT/β-catenin pathways in kidney.\",\n      \"method\": \"Transgenic mouse model with ALK3QD; histological analysis; co-immunoprecipitation of SMAD1/β-catenin/SMAD4 complexes; Tcf-lacZ reporter assay\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic gain-of-function plus co-IP and reporter assay, single lab\",\n      \"pmids\": [\"12736218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BMP4 signals through ALK3 (BMPR1A) and Smad5 in spermatogonia; BMP4 stimulation induces Smad4/5 nuclear translocation and formation of a DNA-binding complex with the transcriptional coactivator p300/CBP, and drives both mitogenic and differentiative effects including Kit expression in undifferentiated spermatogonia.\",\n      \"method\": \"Cell culture of spermatogonia with BMP4; immunofluorescence for nuclear translocation; DNA-binding complex analysis; [3H]thymidine incorporation; Kit expression assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal in vitro readouts (translocation, complex formation, proliferation, differentiation), single lab\",\n      \"pmids\": [\"12857787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ALK3 (BMPR1A) controls ureteric bud branching morphogenesis in vivo; ureteric bud-specific deletion of Alk3 causes abnormal primary branching pattern, followed by fewer branches, and postnatal renal dysplasia with abnormal β-catenin and c-MYC expression in medullary tubules.\",\n      \"method\": \"Ureteric bud-specific conditional knockout (Alk3-UB-/-); renal morphological analysis at multiple developmental stages; molecular marker analysis\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with defined temporal phenotypic analysis and molecular readouts\",\n      \"pmids\": [\"18178801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Prenatal abrogation of Alk3 in lung epithelial cells impairs distal airway formation, reduces cell proliferation and differentiation, disrupts surfactant secretion, and perturbs canonical Wnt signaling possibly through reduced Wnt inhibitory factor-1 expression.\",\n      \"method\": \"Inducible epithelial-specific conditional knockout (SPC-rtTA/TetO-Cre x Alk3-flox); analysis at multiple developmental timepoints; Wnt pathway marker expression\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible conditional KO at two timepoints with defined molecular mechanism linking ALK3 to Wnt signaling via Wif1\",\n      \"pmids\": [\"18258849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TβRIII (betaglycan) differentially modulates ALK3 and ALK6 subcellular trafficking and downstream signaling: TβRIII associates with ALK3 primarily through extracellular domains and causes cell surface retention of ALK3 (independent of β-arrestin2), specifically enhancing ALK3-mediated ID-1 upregulation; in contrast, TβRIII/ALK6 interaction requires cytoplasmic domains and promotes ALK6 internalization.\",\n      \"method\": \"Co-immunoprecipitation; cell surface retention assays; reporter gene assays (XVent2, 3GC2); domain deletion mutants; β-arrestin2 mutant TβRIII\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, domain-mapping mutants, and functional reporter assays, multiple orthogonal methods\",\n      \"pmids\": [\"19726563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BMPR1A and ACVR1 (type I BMP receptors) activate multiple signaling pathways to regulate lens formation; BMPR1A specifically regulates cell survival, while ACVR1 regulates proliferation; for most lens development processes (placode proliferation, FoxE3 expression, αA-crystallin, lens invagination), BMP receptor signaling acts in a Smad-independent manner; only maintaining high Sox2 levels requires canonical Smad4-dependent signaling.\",\n      \"method\": \"Conditional knockout of Bmpr1a, Acvr1, Smad4, Smad1, Smad5 in lens ectoderm; cellular and molecular phenotypic analysis; epistasis analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic conditional KO of multiple pathway components establishing Smad-independent vs Smad-dependent pathway hierarchy\",\n      \"pmids\": [\"19733164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BMPR1a and BMPR1b exert opposing effects on astrocytic hypertrophy after spinal cord injury; BMPR1a ablation in GFAP+ cells leads to defective astrocytic hypertrophy, while BMPR1b null mice develop hyperactive reactive astrocytes; the two receptors oppositely regulate posttranscriptional levels of astrocytic microRNA-21, which controls astrocyte size.\",\n      \"method\": \"Conditional knockout (GFAP-Cre); BMPR1b global knockout; double knockout rescue; in vitro astrocyte culture; microRNA-21 overexpression experiments\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO, global KO, double KO rescue, and in vitro overexpression establishing opposing functions and miR-21 as downstream effector\",\n      \"pmids\": [\"20130193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Bmpr1a is required in the epiblast to maintain Wnt signaling in the visceral endoderm, which in turn establishes the anterior Dkk1 expression domain needed for directional AVE migration; Bmpr1a in epiblast induces Wnt3/Wnt3a expression, thereby maintaining WNT signaling that restricts Dkk1 to the anterior proximal visceral endoderm.\",\n      \"method\": \"Bmpr1a null and epiblast-specific conditional knockout (Sox2Cre); WNT3A rescue experiments in embryo culture; in situ hybridization for Dkk1 and Cer1\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional and null KO with pathway rescue experiment establishing BMPR1A upstream of WNT3A/Dkk1 axis\",\n      \"pmids\": [\"20211162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Granulosa cell-expressed BMPR1A and BMPR1B act redundantly to suppress ovarian tumor development; BMPR1A single conditional knockout females are subfertile with reduced ovulation; double Bmpr1a/Bmpr1b mutants develop granulosa cell tumors with increased TGFβ and hedgehog signaling, similar to Smad1/Smad5 double knockouts.\",\n      \"method\": \"Single and double granulosa cell-specific conditional knockouts; tumor phenotype analysis; pathway marker analysis (TGFβ, hedgehog)\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis through double conditional KO placing BMPR1A/BMPR1B upstream of TGFβ/hedgehog in ovarian tumor suppression\",\n      \"pmids\": [\"20363875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Bmpr1a signaling in palatal mesenchyme is required for cell proliferation in the primary and anterior secondary palate and for osteoblast differentiation during palatal bone formation; Bmpr1a loss reduces Msx1 and Fgf10 in palatal mesenchyme and Shh in palatal epithelium, indicating Bmp signaling regulates mesenchymal-epithelial crosstalk.\",\n      \"method\": \"Palatal mesenchyme-specific conditional knockout; proliferation analysis; in situ hybridization for Msx1, Fgf10, Shh\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple molecular pathway readouts establishing signaling hierarchy\",\n      \"pmids\": [\"21185278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Conditional deletion of Bmpr1a in differentiated osteoclasts (Ctsk-Cre) increases osteoblastic bone formation rates in remodeling bone and increases bone volume; expression of bone-resorption markers was increased, suggesting BMPR1A signaling negatively regulates osteoclast differentiation; comparison with osteoblast-specific Bmpr1a deletion (Col1a1-Cre) showed opposite effects on bone formation rate.\",\n      \"method\": \"Osteoclast-specific and osteoblast-specific conditional knockouts; bone histomorphometry; bone marker analysis\",\n      \"journal\": \"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two distinct conditional KO lines with cell-type-specific phenotypes, histomorphometric quantification\",\n      \"pmids\": [\"21786321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BMP15 suppresses progesterone production in human granulosa cells by downregulating StAR via ALK3-mediated SMAD1/5/8 signaling; siRNA-mediated depletion of ALK3 reverses BMP15-induced SMAD1/5/8 phosphorylation and StAR expression changes.\",\n      \"method\": \"siRNA knockdown of ALK3 in immortalized (SVOG) and tumor (KGN) human granulosa cells; pharmacological inhibition with dorsomorphin and DMH-1; SMAD1/5/8 phosphorylation assays; StAR and progesterone measurement\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA knockdown confirmed in two cell lines plus pharmacological inhibition, multiple orthogonal methods\",\n      \"pmids\": [\"24140593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BMP signaling via ALK3 in SHF-derived cells at the cardiac venous pole is required for proliferative expansion of the DMP progenitor population; conditional deletion of Alk3 from venous pole SHF cells impairs DMP formation and causes ostium primum defect with decreased proliferative index of SHF cells.\",\n      \"method\": \"SHF-specific conditional knockout; proliferative index measurement; DMP volume analysis; BMP/TGFβ signaling marker analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with quantitative proliferation and volume measurements, defined mechanistic pathway\",\n      \"pmids\": [\"23584254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"USP15 deubiquitylates ALK3 (BMPR1A): USP15 interacts with SMAD6 and ALK3, removes K48-linked polyubiquitin from ALK3, stabilizes ALK3 protein, and enhances BMP-induced SMAD1 phosphorylation and BMP target gene transcription; loss of USP15 increases ALK3 ubiquitylation and reduces BMP signaling and osteoblast differentiation.\",\n      \"method\": \"Co-immunoprecipitation; RNAi depletion; ubiquitylation assays (K48-linked); SMAD1 phosphorylation assays; reporter assays; Xenopus embryogenesis functional validation\",\n      \"journal\": \"Open biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct deubiquitylation assay with K48-linkage specificity, reciprocal co-IP, functional rescue in multiple systems\",\n      \"pmids\": [\"24850914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HFE interacts with ALK3 (BMPR1A), inhibiting ALK3 ubiquitination and proteasomal degradation, thereby increasing ALK3 protein expression and cell-surface accumulation, which enhances SMAD1/5/8 phosphorylation and hepcidin expression; HH-associated HFE mutants (C282Y and H63D) fail to increase ALK3 cell-surface expression.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitylation assays; cell-surface expression analysis; HFE overexpression/inhibition in Hep3B cells; Hfe knockout mouse liver analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP, ubiquitylation assay, cell-surface analysis, in vivo mouse validation, and disease-mutant characterization\",\n      \"pmids\": [\"24904118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Alk3-mediated BMP signaling in epicardium-derived cells (EPDCs) is required for their contribution to the AV sulcus, annulus fibrosus, and parietal leaflets of AV valves; deletion of Alk3 in Wt1+ epicardial cells reduces EPDC contribution and causes myxomatous valve changes.\",\n      \"method\": \"Wt1-Cre epicardial conditional knockout; cell fate tracing; electrophysiology; histological and morphological analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with lineage tracing and electrophysiological analysis, single lab\",\n      \"pmids\": [\"25300579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BMPR1A signaling in the uterus is necessary for blastocyst attachment; conditional knockout of ALK3 in the uterus causes sterility with defects in luminal epithelium polarity, increased microvilli density, elevated estrogen response, and unopposed epithelial proliferation; SMAD4 and progesterone receptor converge on Klf15 transcription to inhibit epithelial proliferation downstream of ALK3.\",\n      \"method\": \"Pgr-Cre conditional knockout; fertility analysis; uterine epithelial morphology; KLF15 dual transcriptional regulation analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined molecular convergence of two pathways (BMP-SMAD4 and progesterone receptor) on Klf15\",\n      \"pmids\": [\"26721398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Physiological BMPR1A signaling in osteoblast lineage exerts dual opposing functions: it restricts preosteoblast (Sp7+) proliferation (suppressing trabecular bone formation) and promotes osteoblast activity/mTORC1 signaling for periosteal bone growth; Smad4 deletion has only minor effects, indicating Bmpr1a uses Smad4-independent effectors to suppress preosteoblast proliferation; mTORC1 inhibition abolishes BMP2-induced protein anabolism in vitro.\",\n      \"method\": \"Dmp1-Cre and inducible Sp7-Cre conditional knockouts; Smad4 conditional KO comparison; bone histomorphometry; mTORC1 signaling assays; in vitro BMP2 treatment with rapamycin\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple Cre lines, Smad4 epistasis analysis, and in vitro pharmacological validation of mTORC1 mechanism\",\n      \"pmids\": [\"26657771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BMP4 and BMP7 suppress StAR expression and progesterone production in human granulosa-lutein cells via ALK3 (not ALK2 or ALK6) and SMAD1/5/8-SMAD4 signaling; siRNA knockdown of ALK3 specifically reverses these effects.\",\n      \"method\": \"siRNA knockdown of ALK3, ALK2, ALK6 in primary and immortalized human granulosa cells; pharmacological inhibition (dorsomorphin, DMH1, SB-431542); SMAD1/5/8 phosphorylation; SMAD4 siRNA knockdown\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA isoform-specific knockdown with pharmacological confirmation and SMAD4 epistasis, two independent cell models\",\n      \"pmids\": [\"26302112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bmpr1a in Myf5/MyoD-expressing myo-endothelial progenitors inhibits intramuscular adipogenesis; Bmpr1a ablation in these cells increases intramuscular fat and decreases myogenic activity, with severely decreased phospho-Smad 1/5/8 signaling; clonal studies show a cell-autonomous switch from myogenic to adipogenic differentiation.\",\n      \"method\": \"Myf5-Cre and MyoD-Cre conditional knockouts; VE-cadherin-Cre lineage tracing; clonal studies of myo-endothelial progenitors; pSmad1/5/8 signaling analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with clonal analysis and signaling readouts, lineage tracing controls\",\n      \"pmids\": [\"24898859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BMP signaling through BMPR1A in osteocytes negatively regulates SOST (sclerostin) and RANKL expression; osteocyte-specific deletion of Bmpr1a (Dmp1-Cre) dramatically increases bone mass, decreases SOST and RANKL, increases OPG, increases β-catenin and Wnt target genes (Tcf1, Tcf3), and reduces osteoclast number.\",\n      \"method\": \"Osteocyte-specific Cre/lox conditional knockout (Dmp1-Cre); micro-CT; histomorphometry; molecular analysis of SOST, RANKL, OPG, β-catenin, Tcf1, Tcf3\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with comprehensive molecular readouts identifying downstream targets in signaling hierarchy\",\n      \"pmids\": [\"27402532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BMP signaling through BMPR1A in osteoclasts suppresses osteoblast mineralization via regulation of connexin 43 (Cx43/Gja1); loss of Bmpr1a in osteoclasts increases Cx43 expression, and Cx43 knockdown in Bmpr1a-null osteoclasts reduces osteoblast mineralization in co-culture, identifying Cx43 as a downstream BMPR1A target mediating osteoclast-osteoblast communication.\",\n      \"method\": \"Co-culture of wild-type osteoblasts with Bmpr1a-null osteoclasts; siRNA knockdown of Cx43/Gja1; mineralization assays\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-culture plus siRNA knockdown, single lab, defined molecular mechanism\",\n      \"pmids\": [\"27649478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BMPR1A is the major type I BMP receptor for Smad-dependent BMP signaling during skull development; pSmad1/5/9 levels are undetectable in Bmpr1a-null cells but not in Bmpr1b or Acvr1 null cells; heterozygous Bmpr1a (but not Bmpr1b or Acvr1) loss rescues constitutively active BMPR1A-induced craniosynostosis by reducing pSmad1/5/9 to normal levels.\",\n      \"method\": \"Conditional knockouts and heterozygous rescues of Bmpr1a, Bmpr1b, Acvr1 in neural crest cells; pSmad1/5/9 quantification in null cells; craniosynostosis phenotypic rescue analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic comparison of three type I receptor knockouts with genetic rescue and signaling quantification\",\n      \"pmids\": [\"28641928\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Endothelial ALK3/BMPR1A and ALK2/ACVR1 are required for postnatal retinal angiogenesis; endothelial-specific inducible deletion of Alk3 delays radial vascular expansion, phenocopying BMPR2 deletion, indicating ALK3 is a key type I receptor partnering with BMPR2 for proangiogenic BMP signaling in retinal vessels.\",\n      \"method\": \"Inducible endothelial-specific conditional knockout; retinal angiogenesis analysis; comparison with Bmpr2, Alk1, Alk2 deletions\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic comparison of multiple receptor conditional KOs establishing receptor partnership\",\n      \"pmids\": [\"28232325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IL-6 enhances BMP-2-induced osteogenic and adipogenic differentiation by promoting cell-surface translocation of BMPR1A, thereby amplifying BMPR1A-mediated BMP/Smad and p38 MAPK pathways.\",\n      \"method\": \"In vitro differentiation assays with human BMSCs; cell-surface translocation assay for BMPR1A; Smad and p38 MAPK signaling analysis; in vivo rat ectopic bone model with IL-6 injection\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo experiments with receptor surface translocation and two downstream pathway readouts, single lab\",\n      \"pmids\": [\"29396550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ALK3 undergoes ligand-independent homodimerization; ALK3 forms heterodimers with ALK2 in a ligand-dependent manner (BMP2 or BMP6 required); both ALK3-ALK3 and ALK2-ALK3 complexes induce hepcidin expression in Huh7 cells; Alk2/Alk3 double hepatocyte-specific deficiency causes greater iron overload than Alk3 deficiency alone.\",\n      \"method\": \"Co-immunoprecipitation in Huh7 cells with and without BMP ligands; hepatocyte-specific double knockout mice; iron overload phenotyping; hepcidin expression assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP with ligand dependence analysis, in vivo genetic epistasis with double KO, functional hepcidin assay\",\n      \"pmids\": [\"30227271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In AML, BMP4 controls expression of the survival factor ΔNp73 through binding to BMPR1A, which in turn directly induces NANOG expression and increases stem-like features in leukemic cells (increased ALDH activity); BMPR1A transcript and membrane receptor are upregulated in AML cells and further increased by BMP4 exposure.\",\n      \"method\": \"Downstream signaling analysis in AML patient cells and cell lines; functional ALDH assay; correlation of ΔNp73, BMPR1A, NANOG expression with patient outcome\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pathway analysis with functional readout (ALDH), but limited mechanistic dissection of direct binding vs signaling intermediates; single lab\",\n      \"pmids\": [\"30262802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ALK2/ALK3 mediate BMP2-induced downregulation of pentraxin 3 (PTX3) in human granulosa-lutein cells via SMAD1/5/8-SMAD4; siRNA knockdown of ALK2/3 or BMPR2/ACVR2A receptors reverses BMP2-induced SMAD1/5/8 phosphorylation and PTX3 downregulation.\",\n      \"method\": \"siRNA knockdown of individual receptors and SMADs; SMAD1/5/8 phosphorylation assays; PTX3 mRNA/protein measurement; BMP receptor inhibitors\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA isoform-specific knockdown in two cell models, pharmacological confirmation, single lab\",\n      \"pmids\": [\"28977600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BMP signaling through ALK3/BMPR1A and SMAD1/SMAD5 controls venous endothelial identity by driving Ephb4 expression; a venous endothelium-specific Ephb4 enhancer shows enriched SMAD1/5 binding and requires SMAD binding motifs; Ephb4 expression is lost upon perturbation of BMP/ALK3 signaling in mice and zebrafish without affecting arterial identity.\",\n      \"method\": \"Genetic perturbations in mice and zebrafish; ChIP/enhancer analysis of SMAD1/5 binding to Ephb4 venous enhancer; SMAD binding motif mutagenesis; in situ hybridization for venous/arterial markers\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic and molecular epistasis in two species, enhancer binding and motif requirement established, multiple orthogonal methods\",\n      \"pmids\": [\"30692543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"S-palmitoylation of BMPR1A regulates its subcellular localization and trafficking, and consequently BMP signaling levels; genetic manipulation of palmitoylation sites on BMPR1A alters its membrane localization and signaling, leading to enhanced oligodendrogenesis from neural stem cells in the mouse brain.\",\n      \"method\": \"Unbiased palmitoylation screen of NSC proteome; site-directed mutagenesis of palmitoylation sites; subcellular localization imaging; BMP signaling assays; in vivo neural lineage analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — unbiased screen identifying palmitoylation, mutagenesis of acylation sites with functional rescue, in vivo lineage consequences\",\n      \"pmids\": [\"31772009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BMPR1A is essential for suture stem cell (SuSC) self-renewal; SuSC-specific disruption of Bmpr1a causes precocious differentiation and craniosynostosis initiated at the suture midline (the stem cell niche); BMPR1A serves as a cell-surface marker of human SuSCs.\",\n      \"method\": \"SuSC-specific conditional knockout; ex vivo stem cell culture; lineage analysis; craniosynostosis phenotyping; human SuSC surface marker characterization\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with ex vivo stem cell validation and human SuSC marker characterization, multiple orthogonal methods\",\n      \"pmids\": [\"33658353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"LAPTM5 recruits WWP2, which binds BMPR1A and mediates its lysosomal sorting, ubiquitination, and degradation; chloroquine (lysosomal inhibitor) restores BMPR1A expression; LAPTM5-driven BMPR1A degradation blocks lung-derived BMP signaling, sustaining cancer stem cell traits and promoting lung-specific metastasis in renal cancer.\",\n      \"method\": \"Co-immunoprecipitation of LAPTM5-WWP2-BMPR1A complex; ubiquitylation assays; chloroquine rescue of BMPR1A expression; conditional KO and overexpression in cancer cells; in vivo metastasis models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP of trimeric complex, ubiquitylation assay, pharmacological and genetic rescue, in vivo validation\",\n      \"pmids\": [\"35842443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Upon BMPR1A activation in endothelial cells, ID2 physically interacts with and sequesters ZEB1, attenuating ZEB1-driven transcription of Tgfbr2, which reduces EC responses to TGFβ and prevents excessive EndoMT; endothelial-specific deletion of Bmpr1a in adult mice causes PAH-like symptoms via excessive EndoMT; siRNA against Tgfbr2 delivered to endothelium ameliorates PAH in Bmpr1a iECKO mice.\",\n      \"method\": \"Endothelial-specific inducible conditional knockout (Bmpr1a iECKO); co-IP of ID2-ZEB1 interaction; lineage tracing of endothelial-derived smooth muscle cells; siRNA lipid nanoparticle rescue; TGFβ response assays\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO, co-IP establishing ID2-ZEB1 physical interaction, lineage tracing, and in vivo rescue establishing causal pathway\",\n      \"pmids\": [\"36166408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BMP-2 and the constitutively active form of ALK3 inhibit renal collecting duct morphogenesis via Smad1 phosphorylation, Smad1/Smad4 complex formation, and Smad1 nuclear translocation; HGF overcomes BMP-2/ALK3 inhibition without interrupting any of these known Smad1 signaling events, indicating parallel pathways downstream of their receptors.\",\n      \"method\": \"Stable expression of constitutively active ALK3 in mIMCD-3 cells; Smad1 phosphorylation and nuclear translocation assays; BMP-responsive promoter (Tlx2) reporter; rescue with HGF and other RTK ligands\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — constitutively active receptor in collecting duct cells with multiple signaling readouts, but limited to negative result for HGF-BMP crosstalk at Smad level\",\n      \"pmids\": [\"10633078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HFE signals predominantly via ALK3 to induce hepcidin in vivo; HFE overexpression in control mice increases hepcidin and pSmad1/5 levels, but overexpression of HFE in hepatocyte-specific Alk3-deficient mice produces no change in hepcidin or pSmad1/5, establishing ALK3 as the required in vivo mediator of HFE-driven hepcidin regulation.\",\n      \"method\": \"AAV2/8-Hfe-Flag injection in hepatocyte-specific Alk3 knockout vs control mice; hepcidin expression; pSmad1/5 measurement; iron and blood parameter analysis\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo gain-of-function in conditional KO background providing direct genetic epistasis evidence\",\n      \"pmids\": [\"30271947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BMPR1A is the preferred BMP2 type I receptor in LβT2 gonadotroph cells for regulating Fshb transcription; siRNA knockdown of endogenous BMPR1A (but not ACVR1 or BMPR1B) significantly impairs BMP2 synergism with activin A on FSHβ reporter activity; constitutively active BMPR1A with BMPR2 stimulates SMAD1/5 phosphorylation and Fshb transcription.\",\n      \"method\": \"siRNA knockdown of BMPR1A, ACVR1, BMPR1B; constitutively active receptor co-expression; Fshb promoter-reporter assay; SMAD1/5 phosphorylation assays\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific siRNA knockdown with pharmacological confirmation, single lab, single cell type\",\n      \"pmids\": [\"19211807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Alk3 controls nephron number and testosterone production via lineage-specific mechanisms in intermediate mesoderm progenitors; in kidney, Alk3 deficiency reduces metanephric blastema contribution and expression of nephron progenitor markers Osr1 and SIX2 via phospho-p38 MAPK pathway; in testis, Alk3 regulates Leydig cell formation via pSMAD1/5/8 signaling.\",\n      \"method\": \"Intermediate mesoderm progenitor-specific conditional knockout; lineage contribution analysis; marker expression; phospho-p38 MAPK and pSMAD1/5/8 analysis in respective tissues\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — lineage-specific conditional KO with pathway-specific signaling readouts (p38 vs SMAD) in two different tissues\",\n      \"pmids\": [\"21613322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BMPR1A mediates BMP signaling-induced deep quiescence in pallial neural stem cells postnatally; Bmpr1a manipulation demonstrates its key role in synchronizing quiescence induction and blockade of glutamatergic neuron differentiation to silence pallial germinal activity after birth.\",\n      \"method\": \"Single-cell RNA sequencing of postnatal dorsal V-SVZ; Bmpr1a genetic manipulation; analysis of NSC quiescence states and neurogenic output\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic manipulation with scRNA-seq molecular characterization, single lab\",\n      \"pmids\": [\"37146152\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BMPR1A (ALK3) is a broadly expressed type I BMP receptor serine/threonine kinase that forms heteromeric complexes with BMP type II receptors (primarily BMPR2), undergoes ligand-independent homodimerization, and is regulated by post-translational mechanisms including ubiquitination/deubiquitination (by SMAD6/SMURF and USP15), lysosomal sorting (via LAPTM5-WWP2), and S-palmitoylation that controls its membrane localization; upon BMP ligand binding it phosphorylates R-SMADs (SMAD1/5/8), enabling their association with SMAD4 and nuclear translocation to regulate target gene transcription, while also activating Smad-independent pathways (p38 MAPK, mTORC1); co-receptors including HFE, TβRIII (betaglycan), and FGFR3 modulate its signaling by stabilizing cell-surface expression or altering trafficking; its context-dependent roles—established by conditional knockout studies—span chondrogenesis, osteogenesis, cardiac valvulogenesis and ventricular development, Müllerian duct regression, hair follicle cycling, lung and kidney branching morphogenesis, pancreatic beta cell insulin secretion, uterine implantation, neural stem cell quiescence, venous endothelial identity, and gastrointestinal polyposis suppression, with its downstream pathway hierarchy variously placing it upstream of Sox9/L-Sox5/Sox6 (cartilage), Wnt/β-catenin, TGFβ2, Dkk1, SOST/RANKL/OPG, ID2-ZEB1-TGFBR2 (EndoMT), and SMAD4-KLF15 (uterine) signaling axes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BMPR1A (ALK3) is a type I BMP receptor serine/threonine kinase that, upon ligand binding, phosphorylates receptor-SMADs (SMAD1/5/8) to drive their association with SMAD4, nuclear translocation, and BMP-responsive transcription [#10, #13]. It functions within heteromeric receptor complexes: ALK3 undergoes ligand-independent homodimerization and forms ligand-dependent heterodimers with ALK2, and co-expression of the type II receptor BMPR2 is required for surface receptor rearrangement and SMAD activation [#11, #37]. Receptor abundance and signaling output are tuned by post-translational control of receptor stability and trafficking — USP15 removes K48-linked polyubiquitin from ALK3 to stabilize it, HFE blocks ALK3 ubiquitination to raise cell-surface levels, the LAPTM5–WWP2 module ubiquitinates ALK3 for lysosomal degradation, and S-palmitoylation governs its membrane localization [#25, #26, #41, #43]. Beyond canonical SMAD signaling, ALK3 engages SMAD-independent effectors including p38 MAPK and mTORC1 [#29, #48]. Through these pathways ALK3 acts as a context-dependent hub across development and tissue homeostasis: it mediates AMH-induced Müllerian duct regression, cardiac valvulogenesis and ventricular morphogenesis, chondrogenesis (redundantly with BMPR1B, upstream of Sox9/L-Sox5/Sox6), skull suture stem-cell self-renewal, hair follicle and lung/kidney branching morphogenesis, and pancreatic beta-cell insulin secretion [#0, #1, #4, #8, #42, #14]. Its downstream hierarchy repeatedly intersects WNT/β-catenin signaling and dedicated effector axes such as SMAD4–KLF15 in uterus, SOST/RANKL/OPG in bone, and ID2–ZEB1–TGFBR2 controlling endothelial-to-mesenchymal transition, with endothelial ALK3 maintaining venous identity via Ephb4 and protecting against PAH-like remodeling [#28, #32, #44, #40].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that ALK3 is a BMP-specific (not TGFβ) type I receptor that phosphorylates R-SMADs to drive SMAD4 complex formation and BMP-responsive transcription, defining its core signaling output.\",\n      \"evidence\": \"Constitutively active receptor reporter assays, co-IP, and nuclear translocation assays for Smad8; constitutively active ALK3 in collecting duct cells with Smad1 readouts\",\n      \"pmids\": [\"10814522\", \"10633078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Used constitutively active constructs rather than ligand-driven activation\", \"Did not address selectivity among BMP ligands at the endogenous receptor\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Conditional knockouts first revealed ALK3's in vivo tissue requirements, linking it to AMH-induced Müllerian duct regression and to cardiac morphogenesis through paracrine TGFβ2 induction.\",\n      \"evidence\": \"Tissue-specific Cre/lox deletion in Müllerian duct mesenchyme and cardiac myocytes with phenotypic and molecular analysis\",\n      \"pmids\": [\"12368913\", \"11854453\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism connecting ALK3 to TGFβ2 transcription not resolved\", \"Receptor partners in these tissues not defined in vivo\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined the receptor-complex requirements for signaling — that BMPRII kinase activity drives ALK3 surface rearrangement — and placed ALK3 upstream of WNT/β-catenin in renal tissue.\",\n      \"evidence\": \"Image correlation spectroscopy of surface clustering with kinase-inactive BMPRII; transgenic ALK3QD with SMAD1/β-catenin/SMAD4 co-IP and Tcf reporter\",\n      \"pmids\": [\"12829744\", \"12736218\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Surface clustering studied in overexpression systems\", \"Physical basis of ALK3–β-catenin pathway convergence not structurally defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed that epithelial ALK3 acts upstream of WNT/β-catenin activation in skin appendages, establishing a recurring BMP→WNT hierarchy in organogenesis.\",\n      \"evidence\": \"Surface-epithelium conditional knockout with nuclear β-catenin and transcription-factor expression analysis; hair follicle conditional knockout\",\n      \"pmids\": [\"15102710\", \"15084466\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link from ALK3/SMAD to β-catenin nuclear entry not mapped\", \"Ligand source in follicle not defined here\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Genetic epistasis placed ALK3 (redundantly with BMPR1B) upstream of the Sox9/L-Sox5/Sox6 cartilage transcription program and defined distinct cardiac valve lineage requirements.\",\n      \"evidence\": \"Cartilage single/double conditional knockouts with Sox factor profiling; AV-canal myocyte conditional deletion with lineage tracing\",\n      \"pmids\": [\"15781876\", \"16037571\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional redundancy obscures ALK3-specific targets\", \"Direct vs indirect regulation of Sox genes unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated autocrine ALK3 signaling controlling epithelial proliferation, survival, and EMT in lung and AV cushion, expanding its role to cell-fate and morphogenetic behaviors.\",\n      \"evidence\": \"Sftpc-cre and Tie1-Cre conditional knockouts with mesenchyme-free culture, genetic Bax rescue, and explant EMT assays\",\n      \"pmids\": [\"16414041\", \"16959237\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SMAD-dependent vs -independent contribution not separated\", \"Downstream cell-cycle effectors only partially identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Extended ALK3 function to endocrine and neural-progenitor contexts, linking BMP4–ALK3 to glucose-stimulated insulin secretion and to progenitor cell-cycle control governing oligodendrocyte fate.\",\n      \"evidence\": \"Beta-cell conditional KO with GTT, transgenic and pharmacological BMP4; olig1-progenitor conditional KO with cell counting and cell-cycle analysis\",\n      \"pmids\": [\"17339028\", \"17626200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in beta cells not defined\", \"Mechanism coupling ALK3 to cell-cycle length unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified co-receptor and isoform selectivity: TβRIII retains ALK3 at the surface to enhance ID-1 signaling, and ALK3 (not ALK2/ALK6) is the preferred receptor for specific BMP transcriptional responses.\",\n      \"evidence\": \"Reciprocal co-IP with domain-mapping mutants and reporter assays; isoform-specific siRNA in gonadotroph cells with constitutively active receptors\",\n      \"pmids\": [\"19726563\", \"19211807\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of receptor-isoform preference not generalized across cell types\", \"β-arrestin-independent retention mechanism incompletely defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Conditional knockouts mapped ALK3 onto multiple WNT-linked developmental axes (epiblast Wnt3a→Dkk1, ureteric bud branching, palatal mesenchymal-epithelial crosstalk) and revealed opposing BMPR1A/BMPR1B effects via miR-21 in astrocytes.\",\n      \"evidence\": \"Sox2Cre/null and tissue-specific conditional KOs with WNT3A rescue, in situ hybridization, and miR-21 overexpression\",\n      \"pmids\": [\"20211162\", \"18178801\", \"21185278\", \"20130193\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional intermediaries between ALK3 and Wnt ligand expression not identified\", \"Mechanism of opposing receptor outputs on miR-21 unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed ALK3 uses different effector branches in a tissue-specific manner — p38 MAPK for nephron progenitor markers versus pSMAD1/5/8 for Leydig cell formation — establishing branch selection as context-dependent.\",\n      \"evidence\": \"Intermediate mesoderm progenitor conditional KO with tissue-specific p38 and SMAD signaling readouts; osteoclast/osteoblast conditional KOs with histomorphometry\",\n      \"pmids\": [\"21613322\", \"21786321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What dictates p38 vs SMAD branch selection unknown\", \"Cell-type-intrinsic determinants of opposing bone outcomes undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined post-translational control of ALK3 abundance: USP15 deubiquitinates and stabilizes ALK3 while HFE blocks its ubiquitination to raise surface levels, both amplifying SMAD signaling, with HFE disease mutants losing this function.\",\n      \"evidence\": \"Co-IP, K48-linkage ubiquitylation assays, RNAi, SMAD1 phospho assays, and in vivo mouse/Xenopus validation\",\n      \"pmids\": [\"24850914\", \"24904118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase opposing USP15 on ALK3 not identified here\", \"Quantitative contribution of receptor turnover to physiological output unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Resolved SMAD-dependent vs -independent effector usage and defined dedicated downstream axes — Smad4–KLF15 in uterus and an mTORC1-dependent anabolic branch in osteoblasts — broadening ALK3's mechanistic repertoire.\",\n      \"evidence\": \"Multiple conditional KOs with Smad4 epistasis, KLF15 dual-pathway transcription analysis, mTORC1 assays with rapamycin, and lens-tissue receptor comparisons\",\n      \"pmids\": [\"26721398\", \"26657771\", \"19733164\", \"24898859\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of Smad4-independent effectors suppressing preosteoblast proliferation incompletely defined\", \"Mechanism coupling ALK3 to mTORC1 not mapped\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified osteocyte and osteoclast BMPR1A targets (SOST/RANKL/OPG and connexin 43) that mediate cell-cell communication controlling bone mass.\",\n      \"evidence\": \"Dmp1-Cre osteocyte conditional KO with micro-CT and molecular profiling; osteoclast-osteoblast co-culture with Cx43 knockdown\",\n      \"pmids\": [\"27402532\", \"27649478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of SOST/RANKL not established\", \"Cx43 regulation studied only in co-culture\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established BMPR1A as the dominant type I receptor for SMAD-dependent BMP signaling in cranial development, since only Bmpr1a loss abolishes pSmad1/5/9 and dose-dependently controls craniosynostosis.\",\n      \"evidence\": \"Systematic conditional KO and heterozygous rescue of Bmpr1a, Bmpr1b, Acvr1 in neural crest with pSmad quantification; endothelial-specific KO retinal angiogenesis comparison\",\n      \"pmids\": [\"28641928\", \"28232325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Basis for ALK3 dominance over other type I receptors unresolved\", \"Receptor-partner stoichiometry in vivo not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Clarified receptor-complex assembly and additional trafficking control: ligand-independent ALK3 homodimers and ligand-dependent ALK2-ALK3 heterodimers both signal, and IL-6 promotes ALK3 surface translocation to amplify SMAD/p38 output.\",\n      \"evidence\": \"Co-IP with/without ligand and hepatocyte double KO iron phenotyping; surface-translocation and signaling assays with IL-6; AML pathway and granulosa-cell siRNA studies\",\n      \"pmids\": [\"30227271\", \"29396550\", \"30262802\", \"28977600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional differences between homodimeric and heterodimeric complexes not dissected\", \"Direct BMPR1A binding vs intermediate signaling in AML not separated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided in vivo genetic proof that ALK3 is the required mediator of HFE-driven hepcidin induction, integrating receptor-stability regulation with systemic iron homeostasis.\",\n      \"evidence\": \"AAV-Hfe overexpression in hepatocyte-specific Alk3 KO vs control mice with hepcidin and pSmad1/5 readouts\",\n      \"pmids\": [\"30271947\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HFE acts solely through stabilization or also via complex assembly not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified S-palmitoylation as a lipid modification controlling ALK3 membrane localization and signaling strength, with consequences for neural stem cell oligodendrogenesis, and defined a direct ALK3/SMAD1/5 transcriptional target (Ephb4) governing venous identity.\",\n      \"evidence\": \"Palmitoylation proteomic screen with acylation-site mutagenesis and in vivo lineage analysis; SMAD1/5 ChIP/enhancer and motif mutagenesis at the Ephb4 venous enhancer in mouse and zebrafish\",\n      \"pmids\": [\"31772009\", \"30692543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Palmitoyl transferase/thioesterase enzymes acting on ALK3 not identified\", \"Generality of Ephb4 regulation beyond venous endothelium untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established ALK3 as a determinant of adult stem-cell self-renewal, marking and maintaining suture stem cells, with loss causing precocious differentiation and craniosynostosis.\",\n      \"evidence\": \"SuSC-specific conditional KO with ex vivo stem cell culture, lineage analysis, and human SuSC surface-marker characterization\",\n      \"pmids\": [\"33658353\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors of ALK3 in stem-cell maintenance not defined\", \"Ligand source in the suture niche unspecified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined a lysosomal degradation route — LAPTM5 recruiting WWP2 to ubiquitinate and degrade BMPR1A — that suppresses BMP signaling and promotes cancer stemness and organotropic metastasis.\",\n      \"evidence\": \"Co-IP of LAPTM5-WWP2-BMPR1A trimeric complex, ubiquitylation assays, chloroquine rescue, and in vivo metastasis models\",\n      \"pmids\": [\"35842443\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal triggering LAPTM5-mediated sorting unknown\", \"Relationship to proteasomal/USP15 regulation not integrated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed ALK3's protective role in adult vasculature and brain: it restrains EndoMT through an ID2-ZEB1-TGFBR2 axis to prevent PAH-like remodeling and induces deep quiescence in pallial neural stem cells.\",\n      \"evidence\": \"Endothelial inducible conditional KO with ID2-ZEB1 co-IP, lineage tracing, and Tgfbr2 siRNA rescue; scRNA-seq with Bmpr1a manipulation in postnatal V-SVZ\",\n      \"pmids\": [\"36166408\", \"37146152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ALK3 activation drives ID2 to outcompete ZEB1 not mechanistically detailed\", \"Effectors of quiescence induction downstream of ALK3 incompletely defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single receptor selects among SMAD-dependent, p38 MAPK, and mTORC1 branches, and how the competing ubiquitination, deubiquitination, palmitoylation, and lysosomal-sorting machineries are integrated to set context-specific signaling thresholds, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model for effector-branch selection\", \"Quantitative interplay of post-translational regulators not reconstituted\", \"Structural basis of complex assembly with type II receptors and co-receptors undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [10, 13, 25, 34]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [10, 34]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [11, 37]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [11, 26, 36, 41]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [43]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 11, 37]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 4, 14, 21]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [25, 26, 41, 43]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BMPR2\", \"ALK2/ACVR1\", \"TGFBR3\", \"HFE\", \"USP15\", \"WWP2\", \"LAPTM5\", \"SMAD4\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}